# Chapter 98: Alcohol Intoxication

# The Biological and Neurological Basis of Alcohol Intoxication

## Introduction

Alcohol intoxication is a transient clinical condition resulting from the recent consumption of ethyl alcohol, leading to disturbances in consciousness, cognition, perception, affect, or behavior (Jain et al., 2015; Sarkar et al., 2023). As a pharmacological intoxicant, alcohol functions as a global central nervous system (CNS) depressant, suppressing the brain and the rest of the CNS (Saunders, 2011; Sarkar et al., 2023; Fair & Akwe, 2015). The brain is a primary target organ for alcohol's actions, and its effects can range from mild behavioral changes to profound coma and even death (Alfonso-Loeches & Guerri, 2011; Jain et al., 2015). The behavioral and psychological manifestations of intoxication, such as mood elevation, disinhibition, impaired judgment, slurred speech, ataxia, and memory impairment, are the direct result of ethanol and its metabolites interacting with complex neurobiological systems (Crichton & Ward, 2013; Pikirenia et al., 2017; Sarkar et al., 2023).

The severity of acute intoxication is generally dose-dependent, with blood alcohol concentrations (BAC) correlating with the degree of psychophysiological disturbance (Jain et al., 2015; Sarkar et al., 2023). However, individual responses are modified by factors such as tolerance developed through chronic use, genetic predispositions, and the presence of other substances (Sarkar et al., 2023; Gram et al., 1993). While acute intoxication is a reversible state, repeated episodes, particularly in the context of alcohol abuse or dependence, can lead to cumulative and sometimes irreversible structural and functional brain damage (Alfonso-Loeches & Guerri, 2011; Slobodin & Odeh, 2015).

Understanding the biological basis of alcohol intoxication is critical, as it provides the foundation for comprehending the mechanisms of alcohol use disorder (AUD), alcohol-related brain damage, and the development of effective treatments. This chapter will provide a comprehensive overview of the biological and neurological underpinnings of alcohol intoxication. It will explore the neuropharmacological effects of ethanol on major neurotransmitter systems, the specific brain regions and neural circuits that are most vulnerable, and the genetic and molecular factors that modulate an individual's response. Furthermore, it will examine neuroimaging findings that reveal alcohol's impact on brain structure and function, the heightened vulnerability during critical neurodevelopmental periods, and the biological rationale for current and emerging therapeutic interventions.

## Neurobiological Systems

The diverse behavioral and cognitive effects of alcohol intoxication stem from its widespread actions on multiple neurotransmitter and neuromodulatory systems in the brain (Pikirenia et al., 2017; Alfonso-Loeches & Guerri, 2011). Ethanol does not bind to a single receptor type but rather modulates the function of numerous membrane proteins, including ligand-gated ion channels and G-protein coupled receptors (Alfonso-Loeches & Guerri, 2011). This broad activity disrupts the delicate balance between neuronal excitation and inhibition, which is fundamental to normal brain function. The primary systems implicated are the GABAergic and glutamatergic systems, which are responsible for the main inhibitory and excitatory drives in the CNS, respectively, as well as key neuromodulatory systems like dopamine, serotonin, and endogenous opioids that regulate mood, motivation, and reward (Eşel, 2006; Fair & Akwe, 2015).

### The GABAergic System
The gamma-aminobutyric acid (GABA) system is the principal inhibitory neurotransmitter system in the brain, and it is a primary target for the acute effects of alcohol (Fair & Akwe, 2015; Eşel, 2006). Ethanol enhances the function of GABA type A (GABA-A) receptors, which are ligand-gated ion channels that permit the influx of chloride ions into the neuron upon activation (Alfonso-Loeches & Guerri, 2011). This influx hyperpolarizes the neuron, making it less likely to fire an action potential, thus increasing overall inhibition in the CNS (Fair & Akwe, 2015). This potentiation of GABAergic transmission is responsible for many of the characteristic effects of intoxication, including sedation, anxiolysis, motor incoordination, and cognitive impairment (Fair & Akwe, 2015; Branin et al., 2017).

Chronic exposure to alcohol leads to neuroadaptive changes in the GABAergic system to counteract the persistent inhibitory tone. The brain compensates by downregulating the function or number of GABA-A receptors, leading to a state of GABA hypofunction (Eşel, 2006; Becker, 2000). When alcohol is abruptly withdrawn, this underlying state of reduced inhibitory control is unmasked, contributing significantly to the hyperexcitability characteristic of the alcohol withdrawal syndrome, which includes symptoms like anxiety, tremor, insomnia, and seizures (Eşel, 2006; Kašpárek et al., 2014; Becker, 2000). The effectiveness of benzodiazepines, which are positive allosteric modulators of the GABA-A receptor, in treating alcohol withdrawal symptoms underscores the critical role of this system (Zutshi et al., 2007; Yersin, 1999). Indeed, perturbations in GABAergic transmission have been implicated in the pathophysiology of both alcohol withdrawal and catatonia, a syndrome that can rarely manifest during withdrawal (Zutshi et al., 2007; Geoffroy et al., 2012).

### The Glutamatergic System
In concert with its effects on inhibition, alcohol also suppresses the primary excitatory neurotransmitter system in the brain, the glutamatergic system (Fair & Akwe, 2015; Eşel, 2006). Ethanol's primary action is to inhibit the function of N-methyl-D-aspartate (NMDA) receptors, a subtype of glutamate receptor critical for synaptic plasticity, learning, and memory (Alfonso-Loeches & Guerri, 2011; Eşel, 2006). This inhibition of NMDA receptor function contributes to the cognitive deficits, memory impairments (blackouts), and sedative effects of acute intoxication (Pikirenia et al., 2017; Molnár et al., 2010). The dose-dependent blockade of memory consolidation, which prevents the transition of short-term memories to long-term storage, is a direct consequence of this glutamatergic disruption (Pikirenia et al., 2017).

As with the GABA system, chronic alcohol exposure leads to compensatory neuroadaptations in the glutamatergic system. The brain upregulates the number or sensitivity of NMDA receptors to overcome the chronic inhibition, resulting in a state of glutamate hyperfunction (Eşel, 2006; Becker & Redmond, 2002). Upon cessation of drinking, this hyperexcitable state is revealed, leading to symptoms of withdrawal such as seizures and delirium (Kašpárek et al., 2014; Becker, 2000). This excessive glutamatergic activity is believed to be a major contributor to alcohol-related brain damage through mechanisms of excitotoxicity, a process where overstimulation of glutamate receptors leads to neuronal death (Alfonso-Loeches & Guerri, 2011; Min et al., 2010; Kvrivishvili & Mitagvariia, 1999). The glutamatergic modulator acamprosate, used to prevent relapse, is thought to work by helping to normalize this imbalance (Dongier, 2003; Pelc, 1997).

### The Dopaminergic System
The rewarding and reinforcing effects of alcohol, which are crucial for the initiation and maintenance of drinking, are primarily mediated by the mesolimbic dopamine system (Weiss & Porrino, 2002; Roberts & Koob, 1997). This pathway, originating in the ventral tegmental area (VTA) and projecting to the nucleus accumbens and prefrontal cortex, is a key component of the brain's reward circuitry (Alfonso-Loeches & Guerri, 2011; Sanchis‐Segura & Spanagel, 2006). Acute alcohol administration increases the firing of dopamine neurons in the VTA and stimulates dopamine release in the nucleus accumbens, producing feelings of euphoria and pleasure (Spanagel, 2003; Kim et al., 2019). This dopaminergic activation serves as a powerful positive reinforcer, motivating further consumption (Miyata & Yanagita, 1998; Lyvers, 1998).

Alcohol's effect on dopamine is not direct but is mediated through its actions on other neurotransmitter systems that modulate the VTA, including GABA, glutamate, and endogenous opioids (Alfonso-Loeches & Guerri, 2011; Branin et al., 2017). For instance, by enhancing GABAergic inhibition of inhibitory interneurons in the VTA, alcohol disinhibits dopamine neurons, leading to increased dopamine release (Branin et al., 2017). Chronic alcohol use leads to neuroadaptations that result in a hypodopaminergic state during withdrawal, contributing to the negative emotional state (dysphoria, anhedonia) that drives continued drinking as a form of negative reinforcement (Koob, 2003; Koob, 2013). This shift from positive to negative reinforcement is a core component of the transition to addiction (George & Koob, 2017).

### Other Neurotransmitter Systems
Alcohol's effects extend to several other important neurochemical systems. The **serotonergic system**, which regulates mood, sleep, and impulse control, is significantly affected (Eşel, 2006; Roberts & Koob, 1997). Chronic alcohol use can lead to lower serotonin levels, which may contribute to comorbid depression and anxiety (Saha, 2015; Schuckit, 1996; McIntosh & Ritson, 2001). The efficacy of selective serotonin reuptake inhibitors (SSRIs) in some subgroups of alcohol-dependent individuals further supports the involvement of this system (Pary et al., 1988).

The **endogenous opioid system** (e.g., endorphins and enkephalins) is also critically involved in the rewarding effects of alcohol (Spanagel, 2003). Alcohol consumption stimulates the release of endogenous opioids, which in turn modulate the dopamine system, contributing to feelings of pleasure (Trachtenberg & Blum, 1987). Some metabolic by-products of ethanol, known as tetrahydroisoquinolines (TIQs), may even interact directly with opioid receptors (Trachtenberg & Blum, 1987). The clinical use of opioid antagonists like naltrexone, which reduces alcohol craving and relapse rates, provides strong evidence for the role of this system in mediating alcohol's reinforcing properties (Dongier, 2003; Tobutt, 2015).

Furthermore, alcohol interacts with the **cholinergic system**, which is vital for attention and memory, contributing to cognitive impairments during intoxication (Alfonso-Loeches & Guerri, 2011). It also impacts **neurotensin** systems, which are involved in modulating alcohol consumption and preference (Rodríguez et al., 2023), and disrupts the **autonomic nervous system**, leading to changes in heart rate, blood pressure, and temperature regulation (Nakamura, 1992; Fair & Akwe, 2015). The complex interplay across these multiple neurobiological systems accounts for the wide-ranging and multifaceted clinical presentation of alcohol intoxication.

## Genetic and Molecular Basis

The variability in individual responses to alcohol, ranging from acute intoxication effects to the long-term risk of developing an alcohol use disorder (AUD), is substantially influenced by genetic and molecular factors (DiMartini, 2007; Blum & Trachtenberg, 1988). While environmental and psychosocial factors are undeniably important, a significant portion of the risk for alcoholism is heritable, suggesting a strong biological underpinning for vulnerability (Cadoret & Winokur, 1972; DiMartini, 2007). These factors shape everything from initial sensitivity to alcohol's effects to the neuroadaptive processes that drive dependence.

### Heritability and Genetic Predisposition
Family, twin, and adoption studies have consistently demonstrated a genetic component to alcoholism (DiMartini, 2007; Cadoret & Winokur, 1972). Having a family history of alcoholism is a robust risk factor for developing the disorder (Roy, 1996; DiMartini, 2007). This genetic predisposition is thought to arise from inherited differences in neurochemical systems that mediate alcohol's effects (Blum & Trachtenberg, 1988). For instance, some theories propose that a pre-existing deficiency in endogenous opioid peptides (endorphins and enkephalins) or altered dopaminergic function may predispose individuals to seek alcohol as a form of "self-medication" to normalize their neurochemical state (Trachtenberg & Blum, 1987; Blum & Trachtenberg, 1988).

Specific gene variants have been investigated as potential contributors to this risk. Genes related to the dopamine system, which is central to reward and reinforcement, are considered prime candidates (Kim et al., 2019). Similarly, genetic polymorphisms in enzymes responsible for alcohol metabolism, such as alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH), can significantly influence drinking behavior and risk for AUD. Variants that lead to rapid accumulation of acetaldehyde, a toxic metabolite of ethanol, produce unpleasant flushing reactions and protect against heavy drinking (Pikirenia et al., 2017). Conversely, other genetic variations in drug oxidation pathways can alter an individual's pharmacokinetic response to alcohol and other substances, potentially increasing susceptibility to toxic effects (Gram et al., 1993).

### Molecular Mechanisms of Alcohol's Action
At the molecular level, ethanol's effects are mediated through its interaction with a variety of membrane proteins (Alfonso-Loeches & Guerri, 2011). As discussed previously, it modulates the function of ligand-gated ion channels, most notably GABA-A and NMDA receptors (Eşel, 2006). However, its influence extends to other channels, including L-type calcium channels and G-protein-coupled inwardly-rectifying potassium (GIRK) channels, as well as intracellular signaling pathways involving protein kinase A (PKA) and protein kinase C (PKC) (Alfonso-Loeches & Guerri, 2011). These widespread interactions disrupt neuronal excitability and synaptic transmission, forming the molecular basis for intoxication (Arias Duque, 2005).

The neurotoxic effects of alcohol are mediated through several parallel molecular pathways. One of the most significant contributors is acetaldehyde, the first metabolite of ethanol, which is a highly reactive and toxic compound that can cause cellular damage (Pikirenia et al., 2017; Alfonso-Loeches & Guerri, 2011). Chronic alcohol consumption also induces a state of oxidative stress, leading to the formation of free radicals that damage lipids, proteins, and DNA within neurons (Alfonso-Loeches & Guerri, 2011; Min et al., 2010).

A growing body of evidence implicates neuroinflammation as a key mechanism of alcohol-induced brain damage (Alfonso-Loeches & Guerri, 2011; Crews & Vetreno, 2015). Alcohol can activate the brain's innate immune system, in part through Toll-like receptor 4 (TLR4) signaling (Alfonso-Loeches & Guerri, 2011). This activation leads to the release of pro-inflammatory cytokines (e.g., TNF-α, IL-1β) by glial cells (microglia and astrocytes), creating a neuroinflammatory environment that contributes to neuronal dysfunction and cell death (Alfonso-Loeches & Guerri, 2011; Malaguarnera et al., 2025). This inflammatory response not only contributes to neurodegeneration but may also alter cognitive processes and promote continued alcohol consumption (Crews & Vetreno, 2015). These molecular events, combined with excitotoxicity from glutamatergic dysregulation, create a cascade of damage that underlies the structural and functional brain changes seen with chronic alcohol abuse (Alfonso-Loeches & Guerri, 2011).

## Brain Structure and Function

The behavioral and cognitive manifestations of alcohol intoxication are direct expressions of its impact on brain structure and function. While acute intoxication produces transient functional disruption, chronic, long-term, and excessive consumption leads to cumulative, and often permanent, structural damage to the brain (Crichton & Ward, 2013; Slobodin & Odeh, 2015). Neuroimaging and neuropathological studies have consistently documented widespread brain abnormalities in individuals with chronic alcoholism, reflecting the neurotoxic consequences of repeated intoxication and withdrawal cycles (Oscar-Berman et al., 1997; Brust, 2002).

### Neuroimaging and Neuropathological Findings
One of the most consistent findings in the brains of chronic alcohol users is generalized brain atrophy, or shrinkage (Slobodin & Odeh, 2015; Crichton & Ward, 2013). This is observable on neuroimaging techniques like computed tomography (CT) and magnetic resonance imaging (MRI) as a reduction in both gray matter and white matter volume (Slobodin & Odeh, 2015; Weis et al., 2019). The volume loss is often accompanied by ventricular enlargement, particularly of the third and lateral ventricles, and sulcal widening, which are secondary to the loss of surrounding brain tissue (Dodd, 2007; Slobodin & Odeh, 2015; Weis et al., 2019).

The effects of alcohol are not uniform across the brain; certain regions appear to be particularly vulnerable. The **frontal lobes** show a disproportionate amount of damage, with significant neuronal loss and white matter shrinkage (Slobodin & Odeh, 2015; Alfonso-Loeches & Guerri, 2011; Dodd, 2007). This is clinically significant as the frontal lobes are critical for executive functions, including planning, decision-making, impulse control, and social cognition (Bernardin et al., 2014; Papazian et al., 2006). The **cerebellum**, particularly the superior vermis, is another area highly susceptible to alcohol-induced degeneration (Pattanashetti & Doddanavar, 2022; Brust, 2002; Weis et al., 2019). Damage to this region underlies the characteristic ataxia, gait disturbance, and problems with motor coordination seen in both acute intoxication and chronic alcoholism (Crichton & Ward, 2013; Laurent & Garnier, 1993).

Other key brain structures affected include those within the limbic system. The **hippocampus**, a region vital for memory formation, experiences neuronal loss and atrophy, contributing to the profound memory deficits associated with alcohol use (Alfonso-Loeches & Guerri, 2011; Saunders, 2011). Diencephalic structures, such as the mammillary bodies and thalamus, are also frequently damaged, especially in the context of thiamine deficiency leading to Wernicke-Korsakoff syndrome (Weis et al., 2019; Hemmingsen et al., 1983). The **corpus callosum**, the large white matter tract connecting the cerebral hemispheres, can also undergo atrophy, contributing to cognitive disconnection syndromes like Marchiafava-Bignami disease (Sharma et al., 2023; Acha Torrez et al., 2012).

### Cognitive and Behavioral Correlates of Brain Changes
The structural brain damage observed in chronic alcoholism has direct functional consequences, manifesting as a wide range of cognitive and behavioral impairments (Page, 1983; Bernardin et al., 2014). These deficits often persist even after a period of abstinence and can significantly impact a person's quality of life and ability to function (Pohl, 1988; Oscar-Berman et al., 1997).

**Cognitive Deficits:**
-   **Memory Impairment:** This is a hallmark of alcohol's effect on the brain. Acute intoxication interferes with the ability to form new memories, which can result in fragmentary memory loss or complete amnesic episodes known as "blackouts" (Saunders, 2011; Pikirenia et al., 2017; Goodwin et al., 1969). Chronic use leads to more persistent deficits in both short-term and long-term memory, particularly episodic memory (the memory of personal events) (Ritz et al., 2012; Bernardin et al., 2014; Violon & Lebrun, 1979). These deficits are strongly linked to dysfunction in the hippocampus and related limbic circuits (Alfonso-Loeches & Guerri, 2011).
-   **Executive Dysfunction:** Reflecting the pronounced damage to the frontal lobes, individuals with long-term alcohol use frequently exhibit impairments in executive functions (Ritz et al., 2012; Herreras & Martínez Gutiérrez, 2008). This includes difficulties with abstract reasoning, problem-solving, planning, cognitive flexibility, and inhibiting inappropriate responses (Page, 1983; Bernardin et al., 2014; Parsons, 1987). These deficits can interfere with treatment adherence and increase the risk of relapse (Cabé et al., 2019).
-   **Visuospatial and Psychomotor Impairments:** Deficits in visuospatial abilities, such as navigating environments or assembling objects, are common and are linked to dysfunction in parietal and frontal regions (Ritz et al., 2012; Page, 1983). Psychomotor slowing, ataxia, and impaired coordination are direct consequences of alcohol's effects on the cerebellum and motor pathways (Crichton & Ward, 2013; Pattanashetti & Doddanavar, 2022).

**Behavioral Manifestations:**
The acute effects of alcohol intoxication on behavior are well-known and include disinhibition, impaired judgment, increased impulsivity, emotional lability, and in some individuals, heightened aggression or irritability (Sarkar et al., 2023; Crichton & Ward, 2013). These behaviors result from the depression of higher-order cortical control centers, particularly in the prefrontal cortex, which normally regulate social conduct and impulse control (Moeller & Dougherty, 2001). Chronic alcohol abuse can lead to more enduring personality changes, including apathy, reduced motivation, poor insight, and social withdrawal, which are consistent with frontal lobe dysfunction (Crichton & Ward, 2013; Oscar-Berman et al., 1997). The combination of cognitive deficits and behavioral dysregulation creates a significant barrier to recovery and contributes to the cycle of addiction (Bernardin et al., 2014; Cabé et al., 2019).

## Developmental Neurobiology

The impact of alcohol on the brain is not uniform across the lifespan; its neurotoxic effects are particularly pronounced during critical periods of brain development (Alfonso-Loeches & Guerri, 2011). Exposure during prenatal development and adolescence—two periods of intense neuronal proliferation, migration, differentiation, and synaptogenesis—can lead to severe and often irreversible structural and functional deficits (Nešpor, 2004; Hyytiä, 2015). Conversely, in older adults, age-related physiological changes can increase vulnerability to alcohol's acute and chronic effects (Graziani, 2011).

### Prenatal Exposure and Fetal Alcohol Spectrum Disorders
The developing fetal brain is exceptionally vulnerable to the teratogenic effects of ethanol (Alfonso-Loeches & Guerri, 2011). Maternal alcohol consumption during pregnancy can lead to a range of physical, behavioral, and learning defects collectively known as Fetal Alcohol Spectrum Disorders (FASD) (Soliz et al., 2009; Evrard, 2010). The most severe presentation is Fetal Alcohol Syndrome (FAS), which is characterized by a triad of symptoms: intrauterine and postnatal growth retardation, specific facial dysmorphisms, and CNS abnormalities (Lewis & Woods, 1994; Evrard, 2010).

The neurological consequences of prenatal alcohol exposure are profound and lifelong (Connor & Streissguth, 1996). Alcohol interferes with numerous developmental processes, including neuronal migration, cell-cell interactions, and gene expression regulation, leading to widespread brain damage (Alfonso-Loeches & Guerri, 2011; Wolraich, 1996). This results in a spectrum of CNS dysfunctions, including microcephaly, mental retardation (intellectual disability), and other neurodevelopmental disorders (Lewis & Woods, 1994; Wolraich, 1996; Evrard, 2010). Behavioral and cognitive deficits are common, manifesting as attention-deficit/hyperactivity disorder (ADHD), poor motor coordination, learning disabilities, and difficulties with problem-solving and judgment (Connor & Streissguth, 1996; Lewis & Woods, 1994). These impairments persist into adolescence and adulthood, often leading to significant challenges in academic, social, and occupational functioning (Evrard, 2010; Brown, 2014).

### Adolescent Vulnerability
Adolescence represents a second critical window of brain maturation, characterized by significant synaptic pruning, myelination, and refinement of neural circuits, particularly within the prefrontal cortex and limbic system (Alfonso-Loeches & Guerri, 2011; Hyytiä, 2015; Lockhart et al., 2018). This ongoing development makes the adolescent brain uniquely susceptible to the neurotoxic effects of alcohol (Nešpor, 2004; Winters & Ingwalson, 2022).

Substantial binge drinking during this period can have particularly detrimental effects, leading to a loss of gray matter and reduced white matter integrity, which can be detected with neuroimaging (Hyytiä, 2015). These structural changes are associated with impairments in a range of cognitive functions, including memory, learning, and executive functions (Hyytiä, 2015; Alfonso-Loeches & Guerri, 2011). Furthermore, early onset of alcohol use during adolescence is a strong predictor for the later development of an alcohol use disorder (Winters & Ingwalson, 2022; McArdle & Angom, 2012; Marttunen & von der Pahlen, 2013). This heightened vulnerability may be due to alcohol's interference with the maturation of reward and impulse-control circuits, leading to long-term alterations in decision-making and motivational processes (López‐Caneda et al., 2013; Winters & Ingwalson, 2022). While some structural changes may be partially reversible with abstinence, the overall impact on an adolescent's functional capacity and long-term mental health can be significant (Hyytiä, 2015).

### Alcohol in the Elderly
In older adults, age-related changes in physiology increase sensitivity to the effects of alcohol (Haaz & Gache, 2007; Graziani, 2011). Reduced body water content, decreased metabolic clearance by the liver, and changes in brain neurochemistry mean that a given amount of alcohol can produce a higher BAC and more pronounced intoxicating effects compared to younger individuals (Whelan, 1995).

Diagnosing alcohol-related problems in the elderly is often complicated by the overlap of symptoms with other common geriatric conditions (Haaz & Gache, 2007; Whelan, 1995). For example, falls, cognitive impairment, confusion, depression, and sleep disturbances can be manifestations of both alcohol misuse and other age-related diseases or dementia syndromes (Graziani, 2011; Whelan, 1995; Avari et al., 2014). This can lead to underdiagnosis and inadequate treatment (Haaz & Gache, 2007; Finlayson, 1995). Furthermore, the high prevalence of polypharmacy in this population increases the risk of dangerous drug-alcohol interactions, particularly with psychotropic agents, sedatives, and cardiovascular drugs, which can potentiate CNS depression and other adverse effects (Gerbino, 1982; Finlayson, 1995). Therefore, alcohol use must be considered in the differential diagnosis for a wide range of geriatric syndromes (Haaz & Gache, 2007; Whelan, 1995).

## Treatment Mechanisms

The management of alcohol intoxication and its sequelae, including withdrawal and dependence, is grounded in an understanding of the underlying neurobiological disruptions caused by ethanol. Pharmacological interventions are designed to either substitute for alcohol's acute effects, restore neurochemical balance, or reduce the motivation to drink by blocking alcohol's rewarding properties (Law & Nutt, 2012). These treatments target the same neurotransmitter systems that are acutely modulated during intoxication and chronically adapted during the development of dependence.

### Management of Acute Intoxication and Withdrawal
Acute alcohol intoxication is typically managed with supportive care, but in severe cases with coma or respiratory depression, life-saving interventions are necessary (Sarkar et al., 2023; Menecier & Rotheval, 2017). The primary goal is to maintain airway, breathing, and circulation while the body metabolizes the alcohol (Sarkar et al., 2023).

The treatment of alcohol withdrawal syndrome (AWS) is a more active process aimed at preventing the progression to severe complications like seizures and delirium tremens (Finn & Crabbe, 1997; Trevisan et al., 1998). The cornerstone of AWS management is the administration of benzodiazepines (Sarkar et al., 2023; Yersin, 1999). These drugs, such as diazepam and lorazepam, are positive allosteric modulators of the GABA-A receptor (Zutshi et al., 2007). By enhancing GABAergic inhibition, they effectively substitute for the CNS depressant effects of alcohol, thereby calming the hyperexcitable state that emerges during withdrawal (Fair & Akwe, 2015; Yersin, 1999). This action mitigates symptoms like agitation, tremor, and anxiety and significantly reduces the risk of seizures (Saitz, 1998; Yersin, 1999). The efficacy of benzodiazepines provides strong clinical evidence for the central role of GABAergic system dysregulation in the pathophysiology of withdrawal (Zutshi et al., 2007). In addition to benzodiazepines, nutritional support, particularly with thiamine (vitamin B1), is critical to prevent Wernicke's encephalopathy, a severe neurological complication of thiamine deficiency common in alcohol-dependent individuals (Sarkar et al., 2023; Hemmingsen et al., 1983).

### Pharmacotherapies for Relapse Prevention
Once detoxification is complete, several medications are available to support abstinence and prevent relapse. These agents target the neurobiological mechanisms underlying craving and the reinforcing effects of alcohol (Pelc, 1997; Dongier, 2003).

**Naltrexone**, an opioid receptor antagonist, is thought to reduce the rewarding effects of alcohol (Dongier, 2003; Tobutt, 2015). By blocking mu-opioid receptors, naltrexone attenuates the alcohol-induced release of dopamine in the nucleus accumbens, thereby diminishing the euphoria and pleasure associated with drinking (Trachtenberg & Blum, 1987; Spanagel, 2003). This reduces the motivation to drink and helps prevent a lapse from escalating into a full-blown relapse (Dongier, 2003).

**Acamprosate** is another key medication for relapse prevention. Its mechanism is believed to involve the modulation of the glutamatergic system (Dongier, 2003). By acting as a weak NMDA receptor antagonist and a GABA-A receptor agonist, acamprosate helps to restore the balance between excitatory and inhibitory neurotransmission that is disrupted by chronic alcohol use (Pelc, 1997; Dongier, 2003). This helps to alleviate the protracted withdrawal symptoms, such as anxiety, insomnia, and dysphoria, that can contribute to craving and relapse (Pelc, 1997).

**Disulfiram** works through a different mechanism: aversive conditioning. It irreversibly inhibits the enzyme aldehyde dehydrogenase, which is responsible for metabolizing acetaldehyde, the primary metabolite of ethanol (Basu et al., 2009). If a person taking disulfiram consumes alcohol, acetaldehyde accumulates in the body, leading to a highly unpleasant reaction that includes flushing, nausea, vomiting, tachycardia, and hypotension (Sahoo & Biswas, 2021). The fear of this reaction acts as a deterrent to drinking (Basu et al., 2009).

### Neuroplasticity, Recovery, and Future Treatments
The potential for cognitive recovery with sustained abstinence highlights the brain's capacity for neuroplasticity (Oscar-Berman et al., 1997; Page, 1983). Studies have shown that some of the cognitive deficits and structural brain changes, such as white matter volume loss, can partially or fully reverse after months or years of sobriety (Bernardin et al., 2014; Page, 1983). This recovery suggests that the brain can repair some of the damage caused by alcohol's neurotoxic effects, although severe conditions like Korsakoff syndrome often involve irreversible neuronal loss (Bernardin et al., 2014; Brand, 2007). Understanding the mechanisms of this recovery is a key area of research and could lead to interventions that promote neurogenesis and synaptic repair. Future therapeutic strategies may target novel mechanisms such as neuroinflammation, oxidative stress, and specific signaling pathways to offer more effective neuroprotection and enhance the brain's natural recovery processes (Alfonso-Loeches & Guerri, 2011; Min et al., 2010).

## Future Directions

While significant progress has been made in elucidating the biological and neurological basis of alcohol intoxication, numerous questions and challenges remain. The complexity of alcohol's interaction with the brain necessitates a continued multidisciplinary research effort to refine our understanding and develop more effective interventions. The existing literature, while broad, points toward several key areas for future investigation.

A primary goal is to achieve a more granular understanding of the molecular mechanisms underlying alcohol's neurotoxic and reinforcing effects (Alfonso-Loeches & Guerri, 2011). While the roles of GABA and glutamate are well-established, the precise subtypes of receptors involved and the downstream signaling cascades that mediate neuroadaptation and damage are still being mapped. Further research is needed to clarify how ethanol modulates specific membrane proteins and ion channels and how these interactions translate into specific behavioral outcomes (Alfonso-Loeches & Guerri, 2011). A deeper knowledge of these pathways could lead to the development of more targeted pharmacotherapies with greater efficacy and fewer side effects. For instance, elucidating the specific mechanisms of neuroinflammation and oxidative stress could yield novel neuroprotective strategies to prevent or mitigate alcohol-related brain damage (Min et al., 2010).

Another critical area is the study of individual differences in vulnerability to alcohol's effects (George & Koob, 2017). It is clear that genetic, developmental, and environmental factors interact to determine why some individuals can engage in moderate drinking without issue while others progress to compulsive use (DiMartini, 2007). Future research should focus on identifying specific genetic markers and epigenetic modifications that confer risk or resilience (Blum & Trachtenberg, 1988). Understanding this heterogeneity is crucial, as it could pave the way for personalized medicine approaches to prevention and treatment (George & Koob, 2017). The observation of diverse cognitive profiles among individuals with alcohol use disorders suggests the existence of distinct neurobiological subtypes that may respond differently to interventions (Page, 1983; Ritz et al., 2012). Characterizing these subtypes through a combination of neuroimaging, genetic analysis, and deep behavioral phenotyping is a promising avenue for future studies.

The neurobiology of craving and relapse also warrants further investigation. While the roles of the dopamine and opioid systems are recognized, the precise neural circuits that encode and retrieve drug-associated memories and trigger craving remain an active area of research (Spanagel, 2003; Franken & Wiers, 2013). Advanced neuroimaging techniques could be used to map these circuits in real-time and observe how they are affected by cues, stress, and therapeutic interventions. This could lead to novel treatments, such as targeted neural stimulation or cognitive training paradigms, designed to weaken the maladaptive motivational processes that drive relapse (Franken & Wiers, 2013).

Furthermore, there is a need for more research into the long-term cognitive and behavioral consequences of alcohol use, particularly patterns like binge drinking which are common in adolescents and young adults (López‐Caneda et al., 2013). Longitudinal studies are essential to track the trajectory of brain development in young drinkers and to determine the extent to which alcohol-induced changes are reversible with abstinence (Hyytiä, 2015). This knowledge is vital for informing public health policies and developing effective prevention programs targeted at this vulnerable population (Marttunen & von der Pahlen, 2013).

Finally, the development of more effective treatments remains a paramount goal. This includes not only novel pharmacotherapies but also understanding the biological mechanisms of existing psychosocial interventions. For example, exploring how cognitive-behavioral therapies or mindfulness-based approaches alter neural circuits related to impulse control and emotional regulation could help optimize these treatments and integrate them more effectively with pharmacological strategies (Byrne et al., 2024). Ultimately, a comprehensive, systems-level understanding of alcohol's impact on the brain will be essential for conquering the immense personal and societal burden of alcohol-related harm.

## Conclusion

Alcohol intoxication is a multifaceted neuropsychiatric syndrome driven by the widespread effects of ethanol on the central nervous system. Its clinical manifestations—from subtle changes in mood and cognition to profound motor impairment and loss of consciousness—are the direct result of disruptions in the delicate balance of neuronal inhibition and excitation. This chapter has synthesized evidence from a range of studies to construct a biological and neurological framework for understanding these effects.

The neuropharmacological actions of alcohol are central to this framework. By enhancing the function of the primary inhibitory neurotransmitter, GABA, and suppressing the primary excitatory neurotransmitter, glutamate, alcohol induces a global depression of CNS activity (Fair & Akwe, 2015; Eşel, 2006). Concurrently, it hijacks the brain's reward pathways, primarily through the modulation of dopamine and endogenous opioid systems, which provides the powerful reinforcing effects that motivate consumption and can lead to addiction (Weiss & Porrino, 2002; Trachtenberg & Blum, 1987).

Chronic exposure to alcohol forces the brain into a state of allostasis, where neuroadaptive changes in these same neurotransmitter systems create a new, pathological equilibrium (Koob, 2003). This altered state is responsible for the phenomena of tolerance and physical dependence, and its unmasking upon cessation of drinking precipitates the potentially life-threatening withdrawal syndrome (Finn & Crabbe, 1997). Repeated cycles of intoxication and withdrawal inflict cumulative damage, leading to measurable structural changes such as cortical atrophy, ventricular enlargement, and degeneration of the cerebellum and frontal lobes (Slobodin & Odeh, 2015; Pattanashetti & Doddanavar, 2022). These structural abnormalities are the substrate for the persistent cognitive deficits in memory, executive function, and motor control that characterize long-term alcohol misuse (Ritz et al., 2012; Page, 1983).

The impact of alcohol is profoundly shaped by individual biology. Genetic predispositions influencing neurotransmitter function and metabolism contribute significantly to an individual's risk for developing an alcohol use disorder (DiMartini, 2007). Moreover, the brain's vulnerability to alcohol's neurotoxic effects varies across the lifespan, with prenatal and adolescent development representing periods of heightened sensitivity (Alfonso-Loeches & Guerri, 2011; Hyytiä, 2015).

A comprehensive understanding of these biological mechanisms is not merely an academic exercise; it is the bedrock of rational therapeutic development. Current treatments, from benzodiazepines for withdrawal management to naltrexone and acamprosate for relapse prevention, are designed to target specific aspects of this neurobiological cascade (Sarkar et al., 2023; Dongier, 2003). As research continues to unravel the molecular pathways of neurotoxicity, neuroinflammation, and neuroplasticity, new opportunities for more targeted and effective interventions will emerge. The ultimate goal is to translate this growing body of knowledge into clinical strategies that can prevent the onset of alcohol-related harm, mitigate its devastating consequences, and promote lasting recovery.

## References

1. Abdel‐Baki, A., Turgeon, N., Chalfoun, C., & Nguyen, A. (2014). Psychose et impulsivité : un mauvais mariage. Psychiatrie et violence. https://doi.org/10.7202/1025225ar
2. Abhilash, K. P., Jha, A., Bandhyopadhyay, R., & Victor, P. (2014). Hypoglycemia - A rare complication of carbamazepine overdose. Indian Journal of Pharmacology. https://doi.org/10.4103/0253-7613.144941
3. Adam, N., Kandelman, S., Mantz, J., Chrétien, F., & Sharshar, T. (2013). Sepsis-induced brain dysfunction. Expert Review of Anti-infective Therapy. https://doi.org/10.1586/eri.12.159
4. Aichmüller, C., & Soyka, M. (2015). Müdigkeit bei Suchterkrankungen. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. https://doi.org/10.4414/smf.2015.02258
5. Akaho, R., & Nishimura, K. (2019). [Neuropsychiatric Systemic Lupus Erythematosus: Psychiatric Symptoms].. PubMed. https://doi.org/10.11477/mf.1416201299
6. Akpınar, A., & Demirdaş, A. (2014). Dissociative Identity Disorder Presenting as a Suicide Attempt or Drug Overdose: A Case Report. Erciyes Medical Journal. https://doi.org/10.5152/etd.2014.7201
7. Albalawi, R., Alsahli, H., Almutairi, N. B., & Alhashemi, M. (2024). Acute psychosis and behavioural changes with seizure-like hyperactive psychomotor activity secondary to isotretinoin initiation in a healthy young male: case report. Annals of Medicine and Surgery. https://doi.org/10.1097/ms9.0000000000001726
8. Alessi, C., & Vitiello, M. V. (2015). Insomnia (primary) in older people: non-drug treatments.. PubMed.
9. Alfonso‐Loeches, S., & Guerri, C. (2011). Molecular and behavioral aspects of the actions of alcohol on the adult and developing brain. Critical Reviews in Clinical Laboratory Sciences. https://doi.org/10.3109/10408363.2011.580567
10. Alromail, N. M. A., Halawani, M. S., & Malawi, I. A. (2017). Emergency Management of Stroke. The Egyptian Journal of Hospital Medicine. https://doi.org/10.12816/0042257
11. Annoni, J., Staub, F., Bruggimann, L., Gramigna, S., & Bogousslavsky, J. (2006). Emotional Disturbances after Stroke. Clinical and Experimental Hypertension. https://doi.org/10.1080/10641960600549173
12. Antón, R., Uribe-viloria, N. D., Sánchez, A. A., Calzón, M. D. L., García, M. G., Astorga, A. Á., Gallego, H. D. L. R., Sánchez, S. G., Canga, C. N., Ojeda, G. M., & Cegama, F. D. U. L. D. (2017). Clinical Features and Diagnosis of Alcoholic Hallucinosis. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.2152
13. Arandjelovic, D., Misic, P., Serafimovic, S., & Petrovic, M. (2010). P01-366 - Psychiatric Syndromes and Disorders in Older Population. European Psychiatry. https://doi.org/10.1016/s0924-9338(10)70574-5
14. Araújo, R. C. B., Gomes, R. M., & Barbosa, M. U. F. (2017). A IMPORTÂNCIA DO BOBATH EM PACIENTES COM PARALISIA CEREBRAL.
15. Arenson, C., Busby‐Whitehead, J., Brummel‐Smith, K., O’Brien, J. G., Palmer, M. H., & Reichel, W. (2010). Evaluation and Management of Dementia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511575952.017
16. Ariaee, N., & Toussi, A. G. (2014). Psychological Effects of Alcohol Abuse. Asia pacific journal of medical toxicology. https://doi.org/10.22038/apjmt.2014.2898
17. Arnold, L. E. (1993). Clinical Pharmacological Issues in Treating Psychiatric Disorders of Patients with Mental Retardation. Annals of Clinical Psychiatry. https://doi.org/10.3109/10401239309148982
18. Attwood, A. S., & Munafò, M. R. (2014). Effects of acute alcohol consumption and processing of emotion in faces: Implications for understanding alcohol-related aggression. Journal of Psychopharmacology. https://doi.org/10.1177/0269881114536476
19. Autor, J. L. M. C., & Principal, C. M. A. C. O. T. (2018). Demencia tipo Alzheimer vs pseudo demencia por depresión. Estudio neuropsicológico de un caso. XII CONGRESO DE POSGRADO EN PSICOLOGÍA | UNAM | 2018.
20. Avari, J., Yuen, G. S., AbdelMalak, B., Mahgoub, N., Kalayam, B., & Alexopoulos, G. S. (2014). Assessment and Management of Late-Life Depression. Psychiatric Annals. https://doi.org/10.3928/00485713-20140306-04
21. Awan, K., & Steinberg, M. H. (2017). Medical Conditions That May Cause Cognitive Impairment and Depression. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199959549.003.0005
22. Ayala, L., Gómez‐Revuelta, M., Requena, C. M., Acilu, E. S. D. A. G. D., Olivares, O. P., Ruíz, M. J., Morales, N. N., Martin, M., Zufiaurre, M. L., Hernández, B., Itoiz, A. A., Peña, M., & González‐Pinto, A. (2017). Clozapine: Since the very beginning?. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.1402
23. Aĭbasova, G. K., & Aĭbasov, E. K. (2003). [Mental disorders in children in the late period after craniocerebral injury].. PubMed.
24. Bach, J. (2015). Unintentional Harm of Older Adults.
25. Bains, N., Abdijadid, S., & Miller, J. (2021). Major Depressive Disorder (Nursing).
26. Balachandra, A., & Ruckmani, V. S. (2015). A Study on Emotional Intelligence, Family Environment, Mental Health Problems & Pro-Social Behavior. JOURNAL OF PSYCHOSOCIAL RESEARCH.
27. Balvir, K. S., Dhanvij, B., Telrandhe, S., & Wajgi, R. D. (2021). A Case Report on Management of Subdural Hematoma. NVEO - NATURAL VOLATILES & ESSENTIAL OILS Journal | NVEO.
28. Baran, A. S. (2003). Sleep Disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511547256.028
29. Barker, R. A., & Redfern, C. (2019). Parkinson’s Disease, Religious Belief and Spirituality. Cambridge University Press eBooks. https://doi.org/10.1017/9781316014165.011
30. Barré, M. (2013). Influence de la cognition sociale (Théorie de l'Esprit) sur la rémission fonctionnelle de la dépression et l'aptitude professionnelle.
31. Basu, D., Sharma, A., & Nebhinani, N. (2009). Disulfiram-induced delirium: diagnostic dilemma.
32. Batinić, B., Duišin, D., & Vukosavljevic-Gvozden, T. (2017). Neurobiological bases for impulsive and compulsive behaviour: Implications for pharmacological and psychological interventions. Engrami. https://doi.org/10.5937/engrami1701017b
33. Batta, A., & Farid, B. (2011). Addiction in Adolescents ---- A Current Trend.
34. Baumeister, R. F., & Heatherton, T. F. (1996). Self-Regulation Failure: An Overview. Psychological Inquiry. https://doi.org/10.1207/s15327965pli0701_1
35. Becker, H. C. (2000). Animal Models of Alcohol Wi t h d r a w a l.
36. Becker, H. C., & Redmond, N. (2002). Role of Glutamate in Alcohol Withdrawal Kindling. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-306-4_25
37. Beed, M., Sherman, R. A., & Mahajan, R. (2013). Neurology. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696277.003.0005
38. Belmaker, R. H. (2007). Treatment of Bipolar Depression. New England Journal of Medicine. https://doi.org/10.1056/nejme078042
39. Berg, A. T. (2011). Epilepsy, cognition, and behavior: The clinical picture. Epilepsia. https://doi.org/10.1111/j.1528-1167.2010.02905.x
40. Bermúdez, C. M., & Barrientos, M. P. S. (2011). Manejo Integral de un paciente con secuelas neuropsiquiátricas por consumo crónico de alcohol. REVISTA MÉDICAS UIS.
41. Bernardin, F., Maheut-Bosser, A., & Paillé, F. (2014). [Cognitive impairment of alcohol-dependent subjects].. PubMed.
42. Bertagnolli, A. C., Kristensen, C. H., & Bakos, D. S. (2014). Dependência de álcool e recaída: considerações sobre a tomada de decisão. Aletheia.
43. Bertón, S. A., & Cash, R. E. (2006). Researching to develop workable models. Parity.
44. Binder, L. M., Spector, J. J., & Youngjohn, J. R. (2012). Psychogenic Stuttering and Other Acquired Nonorganic Speech and Language Abnormalities. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acs051
45. Bitnun, A., & Richardson, S. E. (2015). Childhood Encephalitis in Canada in 2015. Canadian Journal of Infectious Diseases and Medical Microbiology. https://doi.org/10.1155/2015/947602
46. Blanco, C., & Bernardi, S. (2014). Gambling Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg62
47. Blay, S. L. (2011). A Case of Major Depressive Disorder and Symptoms of Polycystic Ovary Syndrome Responding to Escitalopram. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.11l01183
48. Blum, K., & Trachtenberg, M. C. (1988). Alcoholism: Scientific Basis of a Neuropsychogenetic Disease. International Journal of the Addictions. https://doi.org/10.3109/10826088809058839
49. Boggs, C. L., Ripple, M., Ali, Z., Brassell, M., Levine, B., Jufer‐Phipps, R., Doyon, S., & Fowler, D. R. (2013). Anaphylaxis After the Injection of Buprenorphine. Journal of Forensic Sciences. https://doi.org/10.1111/1556-4029.12161
50. Bordini, L., Riboldi, L., & Ferrario, M. (2013). [Psychotropic substances and driving].. PubMed.
51. Borie, Y. A., Tamiso, A., Gutema, K., Jisso, M., Deribe, B., Fikre, R., Defar, S., Ayalew, M., & Abera, W. (2024). Psychological distress and its associated factors among people with specific chronic conditions (diabetes and/or hypertension) in the Sidama region of southern Ethiopia: A cross-sectional study. PLoS ONE. https://doi.org/10.1371/journal.pone.0303196
52. Borowski, M. (2013). Addiction as a Disease. European Researcher. https://doi.org/10.13187/er.2013.55.1945
53. Bosch, W. V. D., & Weel‐Baumgarten, E. V. (2003). [Depression: longer-lasting episode not an automatic indication for referral].. PubMed.
54. Bouras, G., & Lazaratou, E. (2012). [Emergence of early childhood trauma in adult psychiatric symptomatology].. PubMed.
55. Bourdeanu, L., Hein, M. J., & Liu, E. A. (2015). Insomnia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190244330.003.0011
56. Bouritius, E. M., Neven, A. K., & Blom, J. D. (2015). [Alcohol hallucinosis].. PubMed.
57. Bradic, L., Lokmić-Pekić, I., & Dzevad, B. (2018). Psychiatric comorbidity in patients with posttraumatic stress disorder and enduring personality change after catastrophic experience. https://doi.org/10.26226/morressier.5b68175cb56e9b005965c22b
58. Braitman, A. L. (2014). Le concept de réactivité cognitive comme marqueur de vulnérabilité psychique du sujet âgé. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2014.09.271
59. Brand, M. (2007). Cognitive profile of patients with alcoholic Korsakoff's syndrome. International Journal on Disability and Human Development. https://doi.org/10.1515/ijdhd.2007.6.2.161
60. Branin, J., Jazi, A. N., Shebak, S. S., & Kim, K. (2017). Alcohol Related Cognitive Impairments: an Overview for Clinical Practitioners. Journal of Geriatrics and Palliative Care. https://doi.org/10.13188/2373-1133.1000020
61. Breuer, L., Kasper, B. S., Schwarze, B., Gschossmann, J. M., Kornhuber, J., & Müller, H. (2015). “Herbal seizures” – atypical symptoms after ibogaine intoxication: a case report. Journal of Medical Case Reports. https://doi.org/10.1186/s13256-015-0731-4
62. Brignole, M., Alboni, P., Benditt, D. G., Bergfeldt, L., Blanc, J., Thomsen, P. E. B., Dijk, J. G. V., Fitzpatrick, A., Hohnloser, S. H., Janousek, J., Kapoor, W. N., Kenny, R. A., Kułakowski, P., Masotti, G., Moyá, A., Raviele, A., Sutton, R., Theodorakis, G., Ungar, A., & Wieling, W. (2004). Guidelines on Management (diagnosis and treatment) of syncope ? update 2004. EP Europace. https://doi.org/10.1016/j.eupc.2004.08.008
63. Brito, A. D. S. (2015). Alcoolismo associado a transtornos mentais..
64. Brown, J. (2014). Fetal Alcohol Spectrum Disorders in the Criminal Justice System: A Review.
65. Brown, S. L. (2006). Deterioration. Epilepsia. https://doi.org/10.1111/j.1528-1167.2006.00682.x
66. Bruna, O., Signo, S., & Subirana-Mirete, J. (2011). Llenguatge i envelliment: una visió des de la neuropsicologia. Aloma: revista de psicologia, ciències de l'educació i de l'esport Blanquerna.
67. Brust, J. C. (2002). Neurologic Complications of Substance Abuse. JAIDS Journal of Acquired Immune Deficiency Syndromes. https://doi.org/10.1097/00126334-200210012-00002
68. Brust, J. C. (2002). Seizures and Illicit Drug Use. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-094-0_11
69. Bryant, L. (2013). Nuggets of Knowledge: Discontinuing medicines in the older person. Journal of Primary Health Care. https://doi.org/10.1071/hc13255
70. Brădeanu, A. V., Tudor, R., Sîrbu, P. D., Ciubară, A., Pascu, L. S., & Ciubară, A. B. (2017). Alcohol Consumption – Implications in Orthopedic Trauma. American Journal of Psychiatry and Neuroscience. https://doi.org/10.11648/j.ajpn.s.2017050601.34
71. Buckley, P., & Foster, A. (2014). Schizophrenia. https://doi.org/10.1007/978-3-7091-0715-7_4
72. Bujosa, C. M., & Monsalve, M. H. (2007). Caso Clínico "La esquizofrenia de inicio senil o cuando el reto de saber pseudodiagnosticar". Norte de Salud mental.
73. Buris, L., Kercs, L., Posta, J., Somogyi, G., & Darok, M. (2001). [Medical judgement on driving capability].. PubMed.
74. Burke, A., Yaari, R., Tariot, P. N., Dougherty, J., Fleisher, A., & Brand, H. (2012). The Shadow People. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.12alz01398
75. Burkhart, P. W. M. K. K. (2014). Drugs Highly Associated with Infusion Reactions Reported using Two Different Data-mining Methodologies. Journal of Blood Disorders & Transfusion. https://doi.org/10.4172/2155-9864.1000195
76. Bush, F. (2015). OPTIONS for Clinical Intervention in Sexual Decisionmaking.. PubMed.
77. Bustos, R., & esmirna, M. (2012). CRITERIOS DE ANALIZABILIDAD EN EL PACIENTE FRONTERIZO.
78. Byard, R. W. (2023). Sports-Related Deaths. CRC Press eBooks. https://doi.org/10.1201/9781003138754-42
79. Byrne, S., Chawla, I., & Hides, L. (2024). Mindfulness and acceptance and commitment therapy for problematic alcohol use and disorders: an updated rapid review.. PubMed. https://doi.org/10.1093/alcalc/agae073
80. Bäckman, L., & Small, B. J. (1998). A continuity view of episodic memory impairment: Illustrations from Alzheimer´s disease and major depression.
81. Cabé, N., Lanièpce, A., Boudehent, C., Vabret, F., & Pitel, A. (2019). [Alcohol induced neurocognitive disorder: screening strategies and tools].. HAL (Le Centre pour la Communication Scientifique Directe).
82. Cadoret, R. J., & Winokur, G. (1972). Genetic Principles in the Classification of Affective Illnesses. International Journal of Mental Health. https://doi.org/10.1080/00207411.1972.11448572
83. Caeiro, L., Ferro, J. M., Melo, T. P. E., Canhão, P., & Figueira, M. L. (2013). Post-Stroke Apathy: An Exploratory Longitudinal Study. Cerebrovascular Diseases. https://doi.org/10.1159/000350202
84. Caeiro, L., Ferro, J. M., Melo, T. P. E., Canhão, P., & Figueira, M. L. (2013). Supplementary Material for: Post-Stroke Apathy: An Exploratory Longitudinal Study. Figshare. https://doi.org/10.6084/m9.figshare.5124829
85. Caixeta, L., Prestes, L. D. S., Oliveira, T. B. D., Silveira, É. A., Barbosa, M. A., & Baldaçara, L. (2024). Aspectos neurocognitivos do alcoolismo. Debates em Psiquiatria. https://doi.org/10.25118/2763-9037.2024.v14.1120
86. Calingasan, N. Y., Sheu, K. R., Baker, H., Gandy, S., & Gibson, G. E. (1996). Thiamine Deficiency as a Model of Selective Neurodegeneration with Chronic Oxidative Deficits. Neurodegenerative Diseases. https://doi.org/10.1007/978-1-4899-0209-2_25
87. Campoy, A. T., Rotger, M. Y., Gutiérrez, L. R. D. L. H., & Pastorelli, R. V. (2011). ¿Psicosis mental injertada o retraso mental? A propósito de un caso.. Psiquiatria.com.
88. Capaldi, D. M., & Kim, H. K. (2014). Comorbidity of Depression and Conduct Disorder. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199797004.013.015
89. Carlin, A., & O'Malley, S. (1996). Neuropsychological Consequences of Drug Abuse. https://doi.org/10.1093/oso/9780195090734.003.0019
90. Castellanos, G., Escobar, A. P., & González, B. G. (2006). Estrés y conducta adictiva. DELETED.
91. Castello, M., Gutiérrez, A. A., Rodríguez, L. S., Pérez, I. S., Arévalo, A. J., & Sempere, E. P. (2025). Acute confusional state vs psychological and behavioral symptoms of dementia. About a case. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2025.1797
92. Catalani, S., & Apostoli, P. (2011). [Neurotoxic effects of cobalt: an open question].. PubMed.
93. Celińska‐Löwenhoff, M., & Musiał, J. (2013). [Psychiatric manifestations of autoimmune diseases--diagnostic and therapeutic problems].. PubMed.
94. Challacombe, F., & Wroe, A. L. (2013). A hidden problem: consequences of the misdiagnosis of perinatal obsessive–compulsive disorder. British Journal of General Practice. https://doi.org/10.3399/bjgp13x667376
95. Chan, H., & Lee, K. (2014). Alcohol withdrawal delirium manifested by manic symptoms in an elderly patient. Psychogeriatrics. https://doi.org/10.1111/psyg.12065
96. Chang, A. N., Kiyokawa, M., & Grysman, N. (2025). Cocaine Induced Postictal Psychosis: a Rare Cause of Antipsychotic Resistant Psychosis. Hawai‘i Journal of Health &amp Social Welfare. https://doi.org/10.62547/nmiq4624
97. Chaouloff, F., Dubreucq, S., Matias, I., & Marsicano, G. (2013). Physical activity feel-good effect:The role of endocannabinoids. Routledge eBooks. https://doi.org/10.4324/9780203132678-12
98. Charante, E. P. M. V., Richard, E., & Perry, M. (2022). [Forgetfulness].. PubMed.
99. Chatterjee, S., Rudra, A., Kirtania, J., Sengupta, S., Moitra, G., Sirohia, S., Wankhade, R., & Banerjee, S. (2006). Postoperative delirium. Indian Journal of Critical Care Medicine. https://doi.org/10.4103/0972-5229.29842
100. Chatterton, C., & Jones, G. (2013). Interpretative aspects of toxicological results. https://doi.org/10.4155/ebo.13.54
101. Chaudhuri, K., Samarakoon, S., Chandola, H., Kumar, R., & Ravishankar, B. (2011). Evaluation of diet and life style in etiopathogenesis of senile dementia: A survey study. AYU (An International Quarterly Journal of Research in Ayurveda). https://doi.org/10.4103/0974-8520.92554
102. Chavan, R., Gosavi, M., Baviskar, M., & Goyal, N. P. (2023). Depression Detection using AI, ML and NLP. International Journal of Advanced Research in Science Communication and Technology. https://doi.org/10.48175/ijarsct-8886
103. Chavarría, A. C. M., Dardón, W. R. G., & Díaz, M. O. H. (2022). TDAH y su relación con eventos cerebrovasculares a futuro. Revista Académica Sociedad del Conocimiento Cunzac. https://doi.org/10.46780/sociedadcunzac.v2i2.45
104. Ciszowski, K., & Mietka-Ciszowska, A. (2013). [Rare consciousness disturbances in toxicological practice: akinetic mutism, somnambulism, locked-in syndrome, and psychogenic coma].. PubMed.
105. Ciszowski, K., & Mietka-Ciszowska, A. (2013). [Toxicant-induced and drug-induced coma neurotoxicological issues of general anesthesia].. PubMed.
106. Colán, T. C., Gálvez, G. A., & Zevallos, D. C. (2013). Síntomas psiquiátricos e insulinoma: reporte de caso Psychiatric symptoms and insulinoma: a case report.
107. Connor, P. D., & Streissguth, A. P. (1996). Effects of Prenatal Exposure to Alcohol Across the Life Span.. PubMed.
108. Conway, K. P., Montoya, I. D., & Compton, W. M. (2007). Lifetime Psychiatric Comorbidity of Illicit Drug Use Disorders. The Psychiatric times.
109. Coronado, L. M. Q., Florez, D. A. C., & Tarazona, M. C. L. (2017). Prevalencia depresión en estudiantes universitarios Bucaramanga 2017.
110. Corruble, E., Warot, D., & Soubrie, C. (2003). Insomnia linked to medications. SLEEP. https://doi.org/10.1007/978-1-4615-0217-3_20
111. Cortés, M. D. C. M. (2013). Análisis evolutivo y valoración neuropsicológica integral de pacientes con deterioro cognitivo leve o enfermedad de Alzheimer..
112. Costa, G. (2012). [Stress of driving: general overview].. PubMed.
113. Costello, C. G. (1969). An Evaluation of Aversion and LSD Therapy in the Treatment of Alcoholism. Canadian Psychiatric Association Journal. https://doi.org/10.1177/070674376901400107
114. Costentin, J. (2015). La dopamine dans tous ses états.
115. Crews, F. T., & Vetreno, R. P. (2015). Mechanisms of neuroimmune gene induction in alcoholism. Psychopharmacology. https://doi.org/10.1007/s00213-015-3906-1
116. Crichton, R. R., & Ward, R. J. (2013). Alcoholic Brain Damage. https://doi.org/10.1002/9781118553480.ch12
117. Crippa, M., Toffoletto, F., & Torri, D. (2007). [Interactions between alcohol and work exposure to chemical substances].. La Medicina del lavoro.
118. Cristovam, M. A. D. S., Muzzolon, S. R. B., & Santos, L. H. C. D. (2019). Application of Youth Self-Report for Age 11-18 for Screening of Mental Disorders in the Adolescence. Mathews Journal of Pediatrics. https://doi.org/10.30654/mjp.10019
119. Cummings, P. M., Trelka, D. P., & Springer, K. M. (2013). Poisoning. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511920905.007
120. Daley, D. C., & Douaihy, A. (2019). Effects of Substance Use Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926632.003.0004
121. Daley, D. C., & Douaihy, A. (2019). Psychiatric Illness Co-occurring with a Substance Use Problem. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926632.003.0008
122. Daley, D. C., & Douaihy, A. (2019). Substance-Related Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926632.003.0002
123. Daley, D. C., & Douaihy, A. (2019). Understanding Substance Use Problems. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926717.003.0002
124. Daras, M., Samkoff, L. M., & Koppel, B. S. (1996). Exacerbation of myasthenia gravis associated with cocaine use. Neurology. https://doi.org/10.1212/wnl.46.1.271
125. Dedeli, Ö., & Akyol, A. D. (2005). Yoğun Bakım Sendromu. Yoğun Bakım Hemşireliği Dergisi.
126. Delcea, C. (2019). Orgasmic disorder in men. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.115
127. Delcea, C. (2019). Orgasmic disorder in women. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.11.122
128. Delcea, C. (2019). Sexual deviances. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.119
129. Delgado, M. G., & Bogousslavsky, J. (2013). Aggravation neurologique après une crise d’épilepsie post-AVC : une paralysie de Todd persistante?.
130. Delgado‐Losada, M. L., Aizcorbe, J. R. R., & Guinea, S. F. (2001). Aspectos de la Neuropsicología Forense en el envejecimiento y en las demencias. Revista de Neurología. https://doi.org/10.33588/rn.3208.2000187
131. Derman, E., Whitesman, S., Dreyer, M., Patel, D., Nossel, C., & Schwellnus, M. (2010). Healthy lifestyle interventions in general practice: Part 12: Lifestyle and depression. South African Family Practice. https://doi.org/10.1080/20786204.2010.10873989
132. Deses, C. D. D. L. (2018). Alteraciones del sueño en personas adultas mayores. Revista de la Facultad de Medicina (México).
133. Dhingra, L., Ahmed, E., Shin, J. G., Scharaga, E., & Magun, M. (2015). Cognitive Effects and Sedation. Pain Medicine. https://doi.org/10.1111/pme.12912
134. DiMartini, A. (2007). Natural history of alcohol use disorders in liver transplant patients. Liver Transplantation. https://doi.org/10.1002/lt.21342
135. Dodd, M. L. (2007). BASIC PRINCIPLES OF PSYCHIATRY. CRC Press eBooks. https://doi.org/10.1201/b14430-11
136. Dodge, N. C., Jacobson, J. L., Lundahl, L. H., & Jacobson, S. W. (2023). Prenatal alcohol exposure and attention‐deficit/hyperactivity disorder independently predict greater substance use in young adulthood. Alcohol Clinical and Experimental Research. https://doi.org/10.1111/acer.15076
137. Dolenc, T. J. (2015). Substance Use Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190214883.003.0044
138. Dongier, M. (2003). What treatment options exist for alcohol abuse?. Journal of Psychiatry and Neuroscience. https://doi.org/10.1139/jpn.0307
139. Dougherty, D. M., & Moeller, F. G. (2001). Antisocial personality disorder, alcohol, and aggression.. PubMed.
140. Douglas, K. S. (2015). Addiction and Violence Risk. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp432
141. Dubovický, M. (2010). Neurobehavioral manifestations of developmental impairment of the brain. Interdisciplinary Toxicology. https://doi.org/10.2478/v10102-010-0012-4
142. Duletic, N., Mijatovic-Papic, T., Cizmovic, B., & Kusturica, S. (2015). Differential Diagnostic Consideration of the Syndrome of Psychomotor Agitation in Geriatric Population. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)31130-5
143. Dunnigan, M., Czapla, K., Henderson, J. B., & Pelosi, A. J. (1999). The Fluid Retention Syndrome: Recognition, Risk Factors and Management. The Journal of the British Menopause Society. https://doi.org/10.1177/136218079900500206
144. Duque, R. A. (2005). Reacciones fisiológicas y neuroquímicas del alcoholismo. Diversitas. https://doi.org/10.15332/s1794-9998.2005.0002.02
145. durantez, E. R. (2006). Neurobiología de la adicción a las sustancias de abuso. DOAJ (DOAJ: Directory of Open Access Journals).
146. Díaz, C. M., Solá, M. G., & Sánchez, M. T. (2013). Enfermedad de Creutzfeldt-Jacob: [caso clínico].
147. Ebenezer, I. S. (2015). Affective Disorders 2: Bipolar Disorder. https://doi.org/10.1002/9781118385777.ch7
148. Ebenezer, I. S. (2015). Drug Abuse and Addiction. https://doi.org/10.1002/9781118385777.ch11
149. Efeoğlu, P., Dağlıoğlu, N., Hilal, A., & Gülmen, M. K. (2013). Drugs Used in Sexual Assaults: Features and Toxicological Investigations. DergiPark (Istanbul University).
150. Escayola, E. N., Caballero, J. M. M.-Q., & Valencia, B. C. (2014). Valoración médico forense de muerte en custodia por delirium agitado. A propósito de un caso.
151. Eskander, F. S. L., Hakim, K. Y. K., Ibrahim, D., & ElMallah, W. (2021). Incidence Of Post-Operative Delirium In Geriatric Patients Undergoing Hip Replacement Surgery Using Pre-Operative Haloperidol. QJM. https://doi.org/10.1093/qjmed/hcab086.109
152. Estroff, T. W., & Gold, M. S. (2022). Medical and Psychiatric Complications of Cocaine Abuse With Possible Points of Pharmacological Treatment. Routledge eBooks. https://doi.org/10.4324/9781003282822-6
153. Evers, M. M., & Marin, D. B. (2002). Mood disorders. Effective management of major depressive disorder in the geriatric patient.. PubMed.
154. Evrard, S. G. (2010). [Diagnostic criteria for fetal alcohol syndrome and fetal alcohol spectrum disorders].. PubMed. https://doi.org/10.1590/s0325-00752010000100011
155. Eşel, E. (2006). [Neurobiology of alcohol withdrawal inhibitory and excitatory neurotransmitters].. PubMed.
156. Fair, N., & Akwe, J. (2015). Alcohol Withdrawal: Prevalence, Trends, and Management.
157. Fama, J. M., & Wilhelm, S. (2010). Obsessions. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0616
158. Farne, H., Norris-Cervetto, E., & Warbrick‐Smith, J. (2015). Blackout. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198716228.003.0009
159. Fatma, S., Sunarti, S., Mardhiyah, F., Wirabhatari, A., & Winstonly, B. (2024). Tantangan Dalam Penilaian Klinis Gejala Depresi pada Usia Lanjut. Jurnal Klinik dan Riset Kesehatan. https://doi.org/10.11594/jk-risk.03.2.6
160. Favrat, B., Guessous, I., Gonthier, A., & Cornuz, J. (2015). [Prolonged or chronic fatigue of unknown origin].. PubMed.
161. Ferlazzo, E. (2010). Confusional status epilepticus in elderly. BMC Geriatrics. https://doi.org/10.1186/1471-2318-10-s1-l35
162. Filho, A. C. O., Gomes, L. M. T., Corrêa, A. C., Leão, E. F. D., Cangussu, D. M., & Torres, S. D. A. S. (2019). BRUXISMO DO SONO. Revista Intercâmbio.
163. Fink, M. (2010). Movement Disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195365740.003.0011
164. Finlayson, R. E. (1995). Misuse of Prescription Drugs. International Journal of the Addictions. https://doi.org/10.3109/10826089509071059
165. Finn, D. A., & Crabbe, J. C. (1997). Exploring alcohol withdrawal syndrome.. PubMed.
166. Fisher, A. D., Bandini, E., Casale, H., & Maggi, M. (2011). Paraphilic Disorders: Diagnosis and Treatment. https://doi.org/10.1002/9781119963820.ch8
167. Foo, Y.-C., Tam, C. L., Ehsan, S. D., & Cheah, J. (2012). Impacts of Drug Use on Memory. AUSTRALIAN JOURNAL OF BASIC AND APPLIED SCIENCES.
168. Forcén, F. E. (2015). Akathisia: Is Restlessness a Primary Condition or an Adverse Drug Effect? Keep a Discerning Eye out for This Adverse Effect of Antipsychotics and Other Drugs. Current psychiatry.
169. Forrest, J., Willis, L., Holm, K., Kwon, M. S., Anderson, M. A., & Foreman, M. D. (2007). Recognizing quiet delirium.. PubMed. https://doi.org/10.1097/01.naj.0000265267.77070.0c
170. Franjić, S. (2023). Post-Traumatic Stress Disorder Appears as a Traumatic Experience. https://doi.org/10.61440/jcpn.2023.v1.04
171. Franken, I. H. A., & Wiers, R. W. (2013). [Motivational processes in addiction: the role of craving, salience and attention].. PubMed.
172. Franklin, K. B. (2013). Mental Illness and Crime. The Encyclopedia of Criminology and Criminal Justice. https://doi.org/10.1002/9781118517383.wbeccj122
173. Gabbard, G. O., & Atkinson, S. (1996). Study guide to treatments of psychiatric disorders. American Psychiatric Press eBooks.
174. Gallino, G., & Liffredo, C. (1993). [Inappropriate drug use in elderly patients. Considerations on various psychologic aspects].. PubMed.
175. Gaona, P., & Shirley, C. (2017). Proceso de atención de enfermería a pacientes con ansiedad relacionada a la abstinencia por alcohol según criterio de diagnostico nanda-nic-noc..
176. Garcia, M. O., Garnica, M. M., Marin, S. G., Martínez, C., Martínez, R. G., & Valle, P. B. D. (2017). A child with Pica. A case presentation. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.472
177. Garcia, P. A. G., & Martinez, A. C. L. (2019). Síndrome de alienación parental: consecuencias en los hijos a nivel psicológico..
178. García, M. D. S., & Calderón, R. M. (2010). Síntomas no motores en la enfermedad de Parkinson y estimulación cerebral profunda. Revista de Neurología. https://doi.org/10.33588/rn.50s02.2009745
179. Garg, T., & Rawat, V. S. (2023). Trihexyphenidyl Use Disorder and Withdrawal Syndrome. Journal of Psychiatry Spectrum. https://doi.org/10.4103/jopsys.jopsys_12_23
180. Garro, A., Bond, G. R., & Gilbert, D. L. (2007). Dyskinesias associated with atomoxetine in combination with other psychoactive drugs. Clinical Toxicology. https://doi.org/10.1080/15563650600981178
181. Garza, G. T., Méndez, M. T. S., & Corral, R. D. (1987). El consumo de alcohol y su relación con la conducta suicida. Salud Mental.
182. Gehricke, J., Loughlin, S. E., Whalen, C. K., Potkin, S. G., Fallon, J., Jamner, L. D., Belluzzi, J. D., & Leslie, F. M. (2007). Smoking to self-medicate attentional and emotional dysfunctions. Nicotine & Tobacco Research. https://doi.org/10.1080/14622200701685039
183. Geoffroy, P. A., Rolland, B., & Cottencin, O. (2012). Catatonia and Alcohol Withdrawal: A Complex and Underestimated Syndrome. Alcohol and Alcoholism. https://doi.org/10.1093/alcalc/agr170
184. George, O., & Koob, G. F. (2017). Individual differences in the neuropsychopathology of addiction. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2017.19.3/gkoob
185. Gerbino, P. P. (1982). Complications of Alcohol Use Combined with Drug Therapy in the Elderly. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.1982.tb01362.x
186. Gheorman, V., Dinescu, V. C., Criciotoiu, O., Stanca, D., Calborean, V., Mită, A., Miscoci, A., Daviţoiu, D. V., Băleanu, V. D., Nedelcuta, R.-M., Dinescu, S. N., Dijmărescu, A. L., Voiculescu, D., & Udriștoiu, I. (2019). Clinical and Biochemical Changes Induced by Alcohol at the Patients with Mental Illness. Revista de Chimie. https://doi.org/10.37358/rc.19.4.7138
187. Ghogare, A. S., Patil, P. S., & Vankar, G. K. (2021). A Systematic Review of Childhood Psychological Traumas and Alexithymia Among Persons with Alcohol Dependence Syndrome. Annals of Indian Psychiatry. https://doi.org/10.4103/aip.aip_54_21
188. Ghosh, S. (2015). Better understanding of etiopathology needed to develop novel treatments. Medicus.
189. Gi, K., & Np, M. (1999). [Current concepts of involvement of glutamate in ischemic damage of the brain tissue].. PubMed.
190. Gilchrist, J. M. (1998). Prognosis in Neurology.
191. Gilg, T. (2012). Psychophysische Leistungsminderungen und Fahrsicherheit, alkoholbedingte Fahruntuechtigkeit bzw. Fahrunsicherheit.
192. Glasper, E. A., McEwing, G., & Richardson, J. M. (2011). Chapter 13 Mental health problems. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199547197.003.0075
193. Gnanamuthu, C. P. (1988). Confusional states and seizures. Postgraduate Medicine. https://doi.org/10.1080/00325481.1988.11700372
194. Goldberg, J. F., Singer, T. M., & Garno, J. L. (2001). Suicidality and substance abuse in affective disorders.. PubMed.
195. Goldfeder, S., Scott, R., & Briggs, J. P. (2023). Forensic Assessments of Alcohol, Cannabis and Methamphetamine Intoxication in Cases of Violent Offending.. PubMed.
196. González, R. M., Quesada, H. S., & Sancho, L. V. (2010). Episodio mixto secundario al uso de fluoxetina en una paciente con un transtorno afectivo bipolar no diagnosticado. Revista Médica de Costa Rica y Centroamérica.
197. González, S. M. B., Campoy, A. T., Carballeda, J. M., Pastorelli, R. V., & Vallejo, J. V. G. (2011). ¿Manía vs psicosis tóxica vs trastornos de conducta? A propósito de un caso.. Psiquiatria.com.
198. Goodwin, D. W., CRANE, J. B., & Guzé, S. B. (1969). Phenomenological Aspects of the Alcoholic “Blackout”. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.115.526.1033
199. Gram, L. F., Brøsen, K., Sindrup, S. H., & Skjelbo, E. (1993). Risk factors in elderly taking psychotropic drugs: Significance of genetic polymorphism in drug oxidation. Nordic Journal of Psychiatry. https://doi.org/10.3109/08039489309102787
200. Grant, J. E., Schreiber, L. R., & Odlaug, B. L. (2013). Phenomenology and Treatment of Behavioural Addictions. The Canadian Journal of Psychiatry. https://doi.org/10.1177/070674371305800502
201. Graziani, P. (2011). La consommation excessive d’alcool chez la personne âgée. Drogues santé et société. https://doi.org/10.7202/1005300ar
202. Greenfield, M. J., Fobian, A. D., Fargason, R. E., & Birur, B. (2024). Optimizing outcomes when treating functional neurological disorder in acute care settings: case reports depicting the value of diagnostic precision and timely and appropriate psychological interventions using an interdisciplinary framework. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2024.1288828
203. Griffiths, M. D., Hodgson, R. J., & Budd, R. (2001). Compulsive Behaviours. Contemporary psychiatry. https://doi.org/10.1007/978-3-642-59519-6_131
204. Griswold, K., Regno, P. A. D., & Berger, R. C. (2015). Recognition and Differential Diagnosis of Psychosis in Primary Care.. PubMed.
205. Guamanarca, R. I. S., Loraque, N. B., Rubio, A. L., García, M. M., Lupiañez, I. J., & Llaría, M. M. M. (2025). SÍNDROME DE EKBOM EN PACIENTE GERIÁTRICO. A PROPÓSITO DE UN CASO.. Revista sanitaria de investigación.. https://doi.org/10.34896/rsi.2025.31.47.002
206. Gupta, K., & Mamidi, P. (2022). Madonmada of Bhela samhita. Journal of Applied Consciousness Studies. https://doi.org/10.4103/ijoyppp.ijoyppp_16_21
207. Gupta, N., Samudra, M., Davis, S., & Javadekar, A. (2021). Intracranial space-occupying lesion masked by alcohol dependence syndrome. Industrial Psychiatry Journal. https://doi.org/10.4103/0972-6748.328845
208. Guskiewicz, K. M., & Goldman, S. B. (2013). A Changing Landscape: Traumatic Brain Injury in Military Combat and Civilian Athletics. The FASEB Journal. https://doi.org/10.1096/fj.13-1101ufm
209. Haaz, S., & Gache, P. (2007). [Medical stakes and prospects in alcohol use amongst the elderly].. PubMed.
210. Hales, R. E., & Yudofsky, S. C. (1996). Synopsis of psychiatry.
211. Hamed, S. A. (2014). Diabetes mellitus and the brain : special emphasis on cognitive function : review. The South African journal of diabetes & vascular disease.
212. Hao, Y., Controzzi, M., Cipriani, C., Popović, D. B., Yang, X., Chen, W., Zheng, X., & Carrozza, M. C. (2013). Controlling hand-assistive devices: utilizing electrooculography as a substitute for vision. IEEE Robotics & Automation Magazine. https://doi.org/10.1109/mra.2012.2229949
213. Harry, P. (1997). [Acute poisoning by new psychotropic drugs].. PubMed.
214. Hawkes, M. A., & Hocker, S. E. (2021). Status Epilepticus. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0057
215. Hemmingsen, R., & Kramp, P. (1988). Delirium tremens and related clilnical states:| Psychopathology, cerebral pathophysiology and psychochemistry: A two‐component hypothesis concerning etiology and pathogenesis. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1988.tb08575.x
216. Hemmingsen, R., Kramp, P., & Rafaelsen, O. J. (1983). Organic cerebral reactions in alcoholism: psychobiological aspects of treatment.. PubMed.
217. Hepsiba, & Raju, M. V. R. (2017). Intellectual Disability. International Research Journal of Engineering IT & Scientific Research. https://doi.org/10.21744/irjeis.v3i5.532
218. Herreras, E. B., & Gutiérrez, G. M. (2008). Adicciones y funcionamiento ejecutivo. Polibea.
219. Herreras, E. B., & Gutiérrez, G. M. (2008). Adicciones y funcionamiento ejecutivo. Psicología y Psicopedagogía.
220. Hers, D., Derely, M., Devos, M., Vandenbosch, M., & Roussaux, J. P. (1988). [Anorexia and drug addiction. Apropos of toxicorexias].. PubMed.
221. Hertz, L., Song, D., Li, B., Du, T., Xu, J., Gu, L., Chen, Y., & Liang, P. (2014). Signal Transduction in Astrocytes during Chronic or Acute Treatment with Drugs (SSRIs, Antibipolar Drugs, GABA-ergic Drugs, and Benzodiazepines) Ameliorating Mood Disorders. Journal of Signal Transduction. https://doi.org/10.1155/2014/593934
222. Holma, I., Holma, K. M., Ketokivi, M., Oquendo, M. A., & Isometsä, E. (2019). The Relationship Between Smoking and Suicidal Behavior in Psychiatric Patients with Major Depressive Disorder.
223. Hong, C. (2013). 분과 심포지움 2. 임상 : 새로운 진단체계 DSM-5; 조현병 스펙트럼 및 기타 정신병적 장애,성격장애. 한국심리학회 연차 학술발표논문집.
224. Hong, C. (2013). 조현병 스펙트럼 및 기타 정신병적 장애, 성격장애. 한국심리학회 학술대회 자료집.
225. Hosztafi, S. (2011). [Heroin addiction].. PubMed.
226. Hsieh, M. T., Peng, W., Wu, C., Ng, K., Cheng, C. Y., & Xu, H. (2010). None. Planta Medica. https://doi.org/10.1055/s-002-20741
227. Hyytiä, P. (2015). [The effect of abused drugs on the developing brain during childhood and adolescence].. PubMed.
228. Häfele, M. (2001). Internistische Differenzialdiagnose bei unklaren Bewusstseinsstörungen in Verbindung mit synkopalen Zuständen oder epileptischen Anfällen. Aktuelle Neurologie. https://doi.org/10.1055/s-2001-15333
229. Hénon, H., & Leys, D. (2007). Delirium and confusional state in stroke patients. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544880.025
230. Hȧrd, E., Archer, T., & Hansen, S. (2003). Animal Models of Mental Retardation. Humana Press eBooks. https://doi.org/10.1385/0-89603-177-2:273
231. Ilbeigi, M. S., Davidson, M., & Yarmush, J. (1998). An Unexpected Arousal Effect of Etomidate in a Patient on High-dose Steroids . Anesthesiology. https://doi.org/10.1097/00000542-199812000-00045
232. Ingrassia, G. F. (2012). HISTORICAL EVOLUTION OF MEDICAL KNOWLEDGE IN THE FIELD OF VEGETATIVE STATE.
233. Irfana, L. (2018). NEUROPATI OPTIK TOKSIK AKIBAT ETAMBUTOL. PROCEEDING UMSURABAYA.
234. Ishii, T. (1987). Clinicopathology of dementias.. Shitsugoshō kenkyū/Shitsugoshou kenkyuu. https://doi.org/10.2496/apr.7.30
235. Iversen, L. L., Iversen, S. D., Bloom, F. E., & Roth, R. H. (2009). Psychedelics. Oxford University Press eBooks. https://doi.org/10.1093/med/9780195380538.003.0606
236. Jaffee, M. S., Broshek, D. K., & Svingos, A. M. (2023). What Is a Concussion?. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780190630119.003.0001
237. Jain, S., Goel, S., & Kapila, S. (2015). Clinical Evaluation Of Psychiatric Emergencies.
238. Jallon, P., & Perrig, S. (2003). [Medications, epileptic crises, and epilepsy].. PubMed.
239. Jarama, D. O. L., Hidalgo, V. N. M., Armas, G. F. V., & Galarza, J. V. A. (2018). Bruxismo un hábito recurrente en jóvenes con ansiedad. RECIMUNDO. https://doi.org/10.26820/recimundo/2.(2).2018.236-258
240. Johansson, B., Andréll, P., Mannheimer, C., & Rönnbäck, L. (2022). [Mental fatigue - possible explanations, diagnostic methods and possible treatments].. PubMed.
241. Joyce, E. M. (2010). Alcoholic and Other Toxic Dementias. https://doi.org/10.1002/9780470669600.ch60
242. Judd, L. L., Schettler, P. J., Brown, E. S., Wolkowitz, O. M., Sternberg, E. M., Bender, B. G., Bulloch, K., Cidlowski, J. A., Kloet, E. R. D., Fardet, L., Joëls, M., Leung, D. Y., McEwen, B. S., Roozendaal, B., Rossum, E. F. C. V., Ahn, J., Brown, D. W., Plitt, A., & Singh, G. (2014). Adverse Consequences of Glucocorticoid Medication: Psychological, Cognitive, and Behavioral Effects. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2014.13091264
243. Juva, K. (2013). [Assessment of legal functional capacity of a neuropsychiatric patient].. PubMed.
244. Kalivas, P. W., Toda, S., Bowers, M. S., Baker, D. L., & Ghasemzadeh, M. B. (2003). The Temporal Sequence of Changes in Gene Expression by Drugs of Abuse. Humana Press eBooks. https://doi.org/10.1385/1-59259-358-5:03
245. Kallenberg, K. S., Grötsch, P., Behrens, A., Strik, H., & Knauth, M. (2006). Zerebrale MRT-Veränderungen in einem Fall von akuter Aceton-Vergiftung?. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. https://doi.org/10.1055/s-2006-941133
246. Kardashyan, R. A., & Pronin, V. Y. (2023). Organic mental disorders with comorbid alcoholism in the elderly. S S Korsakov Journal of Neurology and Psychiatry. https://doi.org/10.17116/jnevro202312312127
247. Karila, L., Lowenstein, W., Coscas, S., Benyamina, A., & Reynaud, M. (2009). [Complications of cocaine addiction].. PubMed.
248. Karila, L., Roux, P., Rolland, B., Benyamina, A., Reynaud, M., Aubin, H., & Lançon, C. (2014). Acute and Long-Term Effects of Cannabis Use: A Review. Current Pharmaceutical Design. https://doi.org/10.2174/13816128113199990620
249. Keary, C. J., Nejad, S. H., Rasimas, J. J., & Stern, T. A. (2013). Intoxications Associated With Agitation, Tachycardia, Hypertension, and Fever: Differential Diagnosis, Evaluation, and Management. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.12f01459
250. Kessels, R. P. C., & Savage, G. (2015). Amnestic Disorders. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp060
251. Khan, S. I. (2021). Loss of appetite.. Preventive Nutrition and Food Science.
252. Kim, H., Park, C. I., Kim, H. W., Kang, J. I., & Kim, S. J. (2019). INFLUENCE OF DOPAMINE-RELATED GENES ON PROBLEMATIC DRINKINGS, IMPULSIVITY AND AGGRESSION IN KOREAN MALE PATIENTS WITH ALCOHOL USE DISORDER. https://doi.org/10.26226/morressier.5d1a037057558b317a14008c
253. Knaap, M. S. V. D., Depienne, C., Sedel, F., & Abbink, T. E. M. (2015). CLCN2-Related Leukoencephalopathy.
254. Knapp, P., & Lightbody, C. E. (2019). Emotional and Cognitive Changes Following a Stroke. https://doi.org/10.1002/9781119581161.ch11
255. Kobayashi, T., Hayakawa, S., Matsuda, M., Tsuchida, H., Haga, H., Tani, N., & Fukui, K. (1999). [Mental and physical symptoms in alcoholics after alcohol withdrawal--comparing with involutional melancholia patients].. PubMed.
256. Koenig, A., DeLozier, I. J., Zmuda, M., Marron, M. M., Begley, A., Anderson, S., Reynolds, C. F., Arnold, S. E., Becker, J. T., & Butters, M. A. (2015). Neuropsychological Functioning in the Acute and Remitted States of Late-Life Depression. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-148006
257. Kokaçya, M. H., Çöpoğlu, Ü. S., Şahpolat, M., & Arı, M. (2015). A Case of Cannabis Use-Associated Psychotic Disorder Accompanied by Autoscopic Phenomena. Addicta The Turkish Journal on Addictions. https://doi.org/10.15805/addicta.2015.2.1.061e
258. Kolla, B., & Hocker, S. E. (2021). Substance Use Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0045
259. Kolomazník, M., & Kolomazník, J. (1998). [Erectile dysfunction].. PubMed.
260. Kondo, T., & Ishiguchi, H. (2007). 3. Drug Induced Dyskinesia. Nihon Naika Gakkai Zasshi. https://doi.org/10.2169/naika.96.1621
261. Kontos, A. P., & McAllister-Deitrick, J. (2017). Concussion in Sport. Oxford Research Encyclopedia of Psychology. https://doi.org/10.1093/acrefore/9780190236557.013.175
262. Koob, G. F. (2003). Alcoholism: Allostasis and Beyond. Alcoholism Clinical and Experimental Research. https://doi.org/10.1097/01.alc.0000057122.36127.c2
263. Koob, G. F. (2013). Neurocircuitry of Addiction: A brain reward deficit, stress surfeit and executive function disorder. Suchttherapie. https://doi.org/10.1055/s-0033-1351398
264. Kotade, K. B., Pandit, B. S., Gaware, V. M., Dolas, R. T., Dhamak, K. B., Somwanshi, S. B., Nikam, V. K., & Khadse, A. N. (2011). KNOWING DEPRESSION AND PHARMACOLOGICAL, NON-PHARMACOLOGICAL APPROACHES FOR ITS TREATMENT.
265. Krivoschekov, S. G. (2011). [Psychophysiology of sports addiction (exercises addiction)].. PubMed.
266. Kumagai, R., & Iseki, E. (2012). [Psychotropic medication of elderly patients].. PubMed.
267. Kumar, S., & Flemming, K. D. (2021). Syndromes of Cognitive Dysfunction. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0076
268. Kunac, A. K. (2014). DEPRESIJA U STARIJOJ ŽIVOTNOJ DOBI-uloga medicinske sestre.
269. Lacomblez, L. (1998). [Drug therapy strategies in Alzheimer's disease].. PubMed.
270. Lafortune, G., Richardson, D., Sassi, F., Cecchini, M., Looper, M. D., Fujisawa, R., Dumont, J., Paris, V., Balestat, G., Notzon, F., Brownwood, I., Sandra, G., Armesto, N., Klazinga, S., Morgan, D., Astolfi, R., & Cave, W. (2009). Suicide. Health at a glance. https://doi.org/10.1787/health_glance-2009-9-en
271. Lam, R. W. (2012). Clinical features and diagnosis. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199692736.003.0004
272. Lance, J. W. (1996). Transient sensations of impending loss of consciousness: the "blip" syndrome.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.60.4.437
273. Lanzaro, M. (2017). A new syndrome? The sport identification addiction and the case of Italian football ultra-fanatical support. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.508
274. Larrieu-Jimenez, P., & Salani, D. (2022). When Moods and Behaviors Do Not Add Up. Journal of Addictions Nursing. https://doi.org/10.1097/jan.0000000000000462
275. Latt, N., Conigrave, K. M., Saunders, J. B., Marshall, E. J., & Nutt, D. (2009). Chapter 10 Other drugs. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199539338.003.0010
276. Laurent, B., & Garnier, P. (1993). [Neurologic emergencies in acute alcoholic intoxication].. PubMed.
277. Lauriat, T. L., & Samson, J. (2015). Endocrine Disorders Associated with Psychological/Behavioral Problems. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199352722.013.32
278. Law, F., & Nutt, D. (2012). Drugs used in the treatment of the addictions. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0158
279. Lawrie, S. M. (2010). Schizophrenia, bipolar disorder, obsessive–compulsive disorder, and personality disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199204854.003.260507
280. Ledezma, C., Soto, K., & Suárez, M. I. (2015). Depresión en el adulto mayor en Costa Rica: un problema social. Revista Hispanoamericana de Ciencias de la Salud.
281. Lee, J. H., Arcinue, E. L., & Ross, B. D. (1994). Organic Osmolytes in the Brain of an Infant with Hypernatremia. New England Journal of Medicine. https://doi.org/10.1056/nejm199408183310704
282. Leonavičius, R., & Adomaitienė, V. (2012). Clinical Case Report of Oniomania. Sveikatos mokslai / Health Sciences. https://doi.org/10.5200/274
283. Lewis, D., & Woods, S. E. (1994). Fetal alcohol syndrome.. PubMed.
284. Lichtenstein, S. V. (2015). Multiple Sklerose – welche Optionen bietet die Ernährungstherapie?. Aktuelle Ernährungsmedizin. https://doi.org/10.1055/s-0035-1552701
285. Lim, H., Cho, Y. S., & Kim, H. J. (2008). Case Reports : A Case of Gluteal Myonecrosis Aggravated after Discharge by Intoxication with Several Drugs Including Tricyclic Antidepressants (TCA). 대한응급의학회지.
286. Llcms, L. C., Martins, P. R. C., Loures, É. N., Vitalino, A. R., Lotufo, C. C., & Onady, S. Y. (2017). ATAQUE ISQUÊMICO TRANSITÓRIO E ESTADO DE MAL EPILÉPTICO COMO MANIFESTAÇÕES DE INTOXICAÇÃO AGUDA E ABSTINÊNCIA POR CRACK E COCAÍNA.
287. Lléo, A., & Blesa, R. (2011). Clinical course of Alzheimer’s disease. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199569854.003.0002
288. Lockhart, S., Sawa, A., & Niwa, M. (2018). Developmental trajectories of brain maturation and behavior: Relevance to major mental illnesses. Journal of Pharmacological Sciences. https://doi.org/10.1016/j.jphs.2018.04.008
289. Logan, B. K., & Couper, F. J. (2003). 3,4-Methylenedioxymethamphetamine - Effects on Human Performance and Behavior.. PubMed.
290. Loitman, J. E., & Deshields, T. L. (2010). Psychiatric Palliative Care Issues. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-590-3_4
291. Lucas, M. (2010). The role of the neuropsychological assessment in relinquishing decision making rights.. African Journal of Psychiatry.
292. Luthra, M. (2017). Depression: Current Scenario with reference to India. Indian Journal of Community Health. https://doi.org/10.47203/ijch.2017.v29i01.001
293. Lyketsos, C. G. (2012). F1‐01‐02: Tackling overlap of neuropsychiatric symptoms in Alzheimer's and other dementias: Toward a unified approach to evaluation and treatment. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2012.05.191
294. Lyvers, M. (1998). Drug addiction as a physical disease: The role of physical dependence and other chronic drug-induced neurophysiological changes in compulsive drug self-administration.. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037//1064-1297.6.1.107
295. Lyvers, M. (1998). Drug addiction as a physical disease: The role of physical dependence and other chronic drug-induced neurophysiological changes in compulsive drug self-administration.. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/1064-1297.6.1.107
296. López, A. M., Martínez, L. R. D., & Moreno, J. (2012). Uso de marcadores bioquímicos para valoración de riesgo de crisis convulsivas en el síndrome de supresión etílica. Salud Mental.
297. López‐Caneda, E., Holguı́n, S. R., Cadaveira, F., Corral, M., & Doallo, S. (2013). Impact of Alcohol Use on Inhibitory Control (and Vice Versa) During Adolescence and Young Adulthood: A Review. Alcohol and Alcoholism. https://doi.org/10.1093/alcalc/agt168
298. Magnin, É., Bustos, E. M. D., & Moulin, T. (2017). Pali and Echo Phenomena: Symptoms of Persistence and Perseveration. Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences. https://doi.org/10.1159/000475692
299. Mahato, T. K., Ojha, S. K., Singh, V., & Parihar, S. P. S. (2021). Addiction withdrawal syndrome: Needs medications, education, counselling &amp; support. World Journal of Advanced Research and Reviews. https://doi.org/10.30574/wjarr.2021.12.2.0573
300. Mahon, S. M., & Carr, E. (2021). Cognitive Dysfunction: Common Side Effect. Clinical journal of oncology nursing. https://doi.org/10.1188/21.cjon.s2.23
301. Mahon, S. M., & Carr, E. (2021). Fatigue/Lack of Endurance: Common Side Effect. Clinical journal of oncology nursing. https://doi.org/10.1188/21.cjon.s2.25
302. Maierà, E. (2010). Old age depression and its treatment.. PubMed.
303. Malaguarnera, M., Rodríguez‐Arias, M., & Miñarro, J. (2025). Neuroinflamación, estrés y consumo de drogas. Revista Española de Drogodependencias. https://doi.org/10.54108/10112
304. Malin, H., & Saleh, F. M. (2007). Paraphilias: Clinical and Forensic Considerations.
305. Manschreck, T. C. (1996). Delusional disorder: the recognition and management of paranoia.. PubMed.
306. Marcello, S., & Silverstein, S. M. (2010). Schizophrenia. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0820
307. Maremmani, I., Pacini, M., Lamanna, F., Pani, P., Perugi, G., Deltito, J., Salloum, I. M., & Akiskal, H. S. (2010). Mood Stabilizers in the Treatment of Substance Use Disorders. CNS Spectrums. https://doi.org/10.1017/s1092852900027346
308. Marks, D. (2003). Classiﬁcation of Seizure Disorders. CRC Press eBooks. https://doi.org/10.1201/9780203912416-48
309. Martins, B. A., Madureira, R. S., Freitas, R. C., & Guidoreni, C. G. (2017). Enxaqueca. Congresso Médico Acadêmico UniFOA.. https://doi.org/10.47385/cmedunifoa.451.4.2017
310. Marttunen, M., & Pahlen, B. V. D. (2013). [Development of substance use disorders can be prevented].. PubMed.
311. Martínez‐Castrillo, J. C., Vela, L., Val, J. D., & Alonso‐Cánovas, A. (2011). Nonmotor Disorders and Their Correlation With Dopamine. The Neurologist. https://doi.org/10.1097/nrl.0b013e318239669f
312. Marzal, G. P., Rigual, F. C., Soto, B. B., & Olivares, J. Q. (2015). Psicoestimulantes en la infancia: ¿Medicalización o mejoramiento?.
313. Masiran, R., & Pang, N. T. P. (2017). Cognitive impairment and depressive symptoms coexisting in an elderly man. BMJ Case Reports. https://doi.org/10.1136/bcr-2016-218267
314. Matuszewska, M., Brzozowska, M., Wardal, W., Furlepa, N., Rzenno, R., Wojciechowska, K., Wicha, K., Sidz, N., Tomaszewska, M., & Jedlikowska, W. (2025). The Long-Term Effects of Alcohol on the Central Nervous System: Mechanisms, Cognitive Decline, and Associated Disorders. Journal of Education Health and Sport. https://doi.org/10.12775/jehs.2025.80.59611
315. McArdle, P., & Angom, B. (2012). Adolescent substance misuse: an update on behaviours and treatments. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.bp.106.003327
316. McIntosh, C., & Ritson, B. (2001). Treating depression complicated by substance misuse. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.7.5.357
317. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). [Clinical practice guideline. Diagnosis and treatment of insomnia in the elderly].. PubMed.
318. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). Diagnóstico y tratamiento del insomnio en el adulto mayor.
319. Meier, L., Weinrebe, W., Annoni, J., & Petersen, J. A. (2022). Confusion and Hallucination in a Geriatric Patient. Pitfalls of a Rare Differential: Case Report of an Anti-LGI1-Encephalitis. Clinical Interventions in Aging. https://doi.org/10.2147/cia.s380316
320. Menecier, P., & Rotheval, L. (2017). L’intoxication éthylique aiguë ou l’ivresse alcoolique. Médecine. https://doi.org/10.1684/med.2017.210
321. Menzel, J. E., & Thompson, J. K. (2010). Food Addiction. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0365
322. Michel, J., Gisselbaek, A., Gauthey, L., & Zelger, G. L. (1993). [Non-compliant drug taking in elderly subjects].. PubMed.
323. Miller, M. W., Marx, B. P., & Keane, T. M. (2010). Posttraumatic Stress Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0699
324. Miller, N., Giannini, A. J., & Gold, M. S. (1992). Suicide risk associated with drug and alcohol addiction. Cleveland Clinic Journal of Medicine. https://doi.org/10.3949/ccjm.59.5.535
325. Miller, S., Schwemmle, C., Jungheim, M., Kühn, D., & Ptok, M. (2015). [Medication-induced dysphagia : A review]..
326. Mimica, N., Presečki, P., Jukić, M. K., & Vitezić, D. (2017). Pharmacotherapy in Alzheimer's disease.
327. Min, J.-A., Kim, D., & Lee, C. U. (2010). Alcohol and brain health: from mechanisms to interventions. Journal of Korean Medical Association. https://doi.org/10.5124/jkma.2010.53.12.1115
328. Miyasato, K. (2013). [Psychiatric and psychological features of nicotine dependence].. PubMed.
329. Miyata, H., & Yanagita, T. (1998). [Mechanism of nicotine dependence].. PubMed.
330. Mohammed, S. A., Saloom, J. E., Obaid, D. H., & Alhuwaizi, A. F. (2023). Malocclusion traits and speech disorders. Medical Journal of Babylon. https://doi.org/10.4103/mjbl.mjbl_570_23
331. Mohedano, C. R., Espárrago‐Llorca, G., & Expósito, L. C. (2011). Comorbilidad psiquiátrica en la dependencia alcohólica (II): Alucinosis alcohólica, celotipia y otros trastornos.
332. Mohr, P. (2022). Treating Catatonia: a Blind Spot of Psychiatry?. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2022.143
333. Molnár, M., Boha, R., Czigler, B., & Gaál, Z. A. (2010). The Acute Effect of Alcohol on Various Memory Processes. Journal of Psychophysiology. https://doi.org/10.1027/0269-8803/a000038
334. Monti, M. M., Laureys, S., & Owen, A. M. (2010). The vegetative state. BMJ. https://doi.org/10.1136/bmj.c3765
335. Moore, K. E., Stein, M. D., Kurth, M. E., Stevens, L., Hailemariam, M., Schonbrun, Y. C., & Johnson, J. E. (2019). Risk factors for self-stigma among incarcerated women with alcohol use disorder.. Stigma and Health. https://doi.org/10.1037/sah0000182
336. MOREIRA, C. D. F. A., Marinho, M., Lourenço, B., Fernandes, C. M., & Mota, T. (2015). Cognitive Impairment in Chronic Alcoholism. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)30410-7
337. Moreira, G. F., Coscarelli, L. P., Jardim, M. C. D., Araújo, I. M. M., Grossi, B. D., Guidi, R. A., Menezes, Y. C. D. C., Silva, I. M., Calmon, M. Z., Neto, C. A. B., Santiago, D. S. D. P., Santos, V. H. R., Souza, L. L., & Silva, C. E. P. (2022). Atualizações sobre a doença de Alzheimer e seus estágios clínicos. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv5n6-016
338. Mossaheb, N., Schloegelhofer, M., Schaefer, M., Fusar‐Poli, P., Smesny, S., McGorry, P. D., Berger, G., & Amminger, G. P. (2012). Long-Chain Omega-3 Fatty Acids and Psychotic Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-62703-215-5_9
339. Moura, G. S., Neves, L. M. T., Giorelli, A. S., Florido, P., & Gomes, M. D. M. (2013). Transtornos do sono: visão geral Sleep disorders: overview.
340. Mueller‐Pfeiffer, C., & Wittmann, L. (2013). Preliminary Investigation of the Reliability and Validity of the German Version of the State Scale of Dissociation (SSD). Journal of Traumatic Stress Disorders & Treatment. https://doi.org/10.4172/2324-8947.1000106
341. Mulinski, P. (1988). Alcoholism and Coexisting Psychiatric Disorders. Families in Society The Journal of Contemporary Social Services. https://doi.org/10.1177/104438948806900302
342. Munir, S., & Takov, V. (2021). Generalized Anxiety Disorder. StatPearls.
343. Munir, S., Takov, V., & Coletti, V. A. (2021). Generalized Anxiety Disorder (Nursing).
344. Murray, R. B. (1996). Stressors and Coping Strategies of Homeless Men. Journal of Psychosocial Nursing and Mental Health Services. https://doi.org/10.3928/0279-3695-19960801-13
345. Murty, V. L., Baid, G. C., Sharma, S., Singh, S. K., Lath, V., & Jena, P. (2023). Obstructive Sleep Apnea: A Prosthodontist’s Viewpoint. Scholars Journal of Dental Sciences. https://doi.org/10.36347/sjds.2023.v10i05.005
346. Muñoz-Lara, J. (2015). Depresión en la persona adulta mayor institucionalizada: Un nuevo reto. Revista Hispanoamericana de Ciencias de la Salud (RHCS).
347. Müller, K., Gehl, A., Ottens, R., & Püschel, K. (2011). [Suicide by hypothermia with intentional partial undressing].. PubMed.
348. Na, I., & Volel, B. A. (2002). [Clinical aspects of "folie du doute"].. PubMed.
349. Nadeem, M. S., Murtaza, B. N., Al-Ghamdi, M. A., Ali, A., Zamzami, M. A., Khan, J. A., Ahmad, A., Rehman, M. U., & Kazmi, I. (2021). Autism - A Comprehensive Array of Prominent Signs and Symptoms. Current Pharmaceutical Design. https://doi.org/10.2174/1381612827666210120095829
350. Naidoo, S. (2015). Managing stress in the dental environment.
351. Nakamura, S. (1992). [Abnormalities of autonomic nervous systems in intoxications, including alcohol and drugs].. PubMed.
352. Nakata, C., Nara, K., Kinoshita, F., Kikuchi, K., & Asai, M. (2015). [Alcohol withdrawal syndrome showing various progress: A case report].. PubMed.
353. Nassisi, D., Korc, B., Hahn, S. A., Bruns, J., & Jagoda, A. (2006). The evaluation and management of the acutely agitated elderly patient.. PubMed.
354. Navarro, C. D., Romero, J. A. A., & Martínez, J. L. G. (1993). Trastornos asociados al juego patológico. Anales de Psicología.
355. Nehretskii, S. (2023). Interdisciplinary Forensic and Pharmaceutical, Organizational and Legal, Clinical and Pharmacological Study of Abuse of Psychoactive Substances. SSP Modern Pharmacy and Medicine. https://doi.org/10.53933/sspmpm.v3i1.85
356. Neto, B. P. F. (2009). Catatonia with Left Temporal Lesion on MRI: Crossing Borders. European Psychiatry. https://doi.org/10.1016/s0924-9338(09)70960-5
357. Neto, L. C. D. S., Miranda, G. A., Cunha, L. L. G. D., Canto, B. E. S., Strufaldi, V. P., Tetti, M. F., Akerman, M., & Matos, L. L. D. (2013). Consequências individuais e socioeconômicas da síndrome da apneia obstrutiva do sono. ABCS Health Sciences. https://doi.org/10.7322/abcshs.v38i1.6
358. Nielsen, J. F., Klemar, B., Hansen, H., & Sinkjær, T. (1995). A new treatment of spasticity with repetitive magnetic stimulation in multiple sclerosis.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.58.2.254-a
359. Nivoli, G., Lorettu, L., Veneto, L. I., Milia, P., Nivoli, L., & Nivoli, A. (2006). Problemi gestionali delle gravi manifestazioni aggressive : Criminalità e spettro dell'umore. https://doi.org/10.1400/91497
360. Nolan, N. M. (2001). Medication‐Induced Taste Disturbances. Nutrition in Clinical Care. https://doi.org/10.1046/j.1523-5408.2001.00110.x
361. Nosek, M. A., & Howland, C. A. (1998). Abuse and Women with Disabilities.
362. Nubukpo, P., Laot, L., & Clément, J. (2012). Addictive behaviors in the aged. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2012.0355
363. Omurzakova, A., Abdurakhmanov, B., Abdykaiymova, G., Barbyshov, I., & Pranayee, R. (2024). STUDYING ATTITUDES TO DEPRESSION AMONG STUDENTS. Bulletin of Osh State University. https://doi.org/10.52754/16948610_2024_2_13
364. Oppenheim, G. (1982). Drug-induced rapid cycling: possible outcomes and management. American Journal of Psychiatry. https://doi.org/10.1176/ajp.139.7.939
365. Orfei, M. D., Robinson, R. G., Prigatano, G. P., Starkstein, S., Rüsch, N., Bria, P., Caltagirone, C., & Spalletta, G. (2007). Anosognosia for hemiplegia after stroke is a multifaceted phenomenon: a systematic review of the literature. Brain. https://doi.org/10.1093/brain/awm106
366. Oscar‐Berman, M., & Mosher, S. M. (2010). Brain Injuries. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0143
367. Oscar‐Berman, M., Shagrin, B., Evert, D. L., & Epstein, C. J. (1997). Impairments of brain and behavior: the neurological effects of alcohol.. PubMed.
368. O’Connor, F. G., & Levine, B. D. (2015). Syncope in Athletes of Cardiac Origin. Current Sports Medicine Reports. https://doi.org/10.1097/01.csmr.0000465136.70746.5b
369. Page, R. D. (1983). Cerebral dysfunction associated with alcohol consumption.. PubMed.
370. Palijan, T. Ž., Kovačević, D., & Turcinović, M. K. (2007). Psychodynamic Characteristics of Ego in Alcoholic Offenders and Non-Offenders. Alcoholism Clinical and Experimental Research.
371. Papazian, Ó., Alfonso, I., & Luzondo, R. (2006). Trastornos de las funciones ejecutivas. Revista de Neurología. https://doi.org/10.33588/rn.42s03.2006016
372. PARISER, S. F., Nasrallah, H. A., & Gardner, D. L. (1997). Postpartum Mood Disorders: Clinical Perspectives. Journal of women's health. https://doi.org/10.1089/jwh.1997.6.421
373. Parker, R. S. (2012). Chronic Posttraumatic Disorders of Consciousness. CRC Press eBooks. https://doi.org/10.1201/b10562-14
374. Parsons, O. A. (1987). Intellectual impairment in alcoholics: Persistent issues. Acta Medica Scandinavica. https://doi.org/10.1111/j.0954-6820.1987.tb13040.x
375. Pary, R., Lippmann, S., & Tobias, C. R. (1988). Depression and Alcoholism: Clinical Considerations in Management. Southern Medical Journal. https://doi.org/10.1097/00007611-198812000-00016
376. Parčina, M. (2017). ORGANIZACIJA RADA USTANOVE ZA ZAPOŠLJAVANJE, RAD I PROFESIONALNU REHABILITACIJU OSOBA S INVALIDITETOM.
377. Pascual‐Leone, Á., Ramachandran, V. S., Cole, J., Sala, S. D., Manly, T., Mayes, A. R., & Sacks, O. (2011). The Paradoxical Brain. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511978098
378. Patel, A., Moreland, T., Haq, F., Siddiqui, F., Mikul, M., Qadir, H., & Raza, S. (2011). Persistent Psychosis After a Single Ingestion of “Ecstasy” (MDMA). The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.11l01200
379. Patricia, G. C. C., AAngela, G.-M., & Marina, R.-A. (2017). Diagnostic and therapeutical challenges of late-onset psychosis.. Journal of Psychology and Cognition. https://doi.org/10.35841/psychology-cognition.2.4.218-220
380. Pattanashetti, L., & Doddanavar, A. (2022). Alcohol Induced Cerebellar Ataxia: A Case Report. Journal of Young Pharmacists. https://doi.org/10.5530/jyp.2022.14.25
381. Paulus, W. J., Reimers, C. D., & Steinhoff, B. J. (2000). Dystonien (unwillkürliche Muskelbewegungen). Steinkopff eBooks. https://doi.org/10.1007/978-3-642-57726-0_16
382. Pechnick, R. N., Cunningham, K. A., & Danovitch, I. (2014). Hallucinogen-Related Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg51
383. Peitl, M. V., Prološčić, J., Zelić, S. B., Skarpa-Usmiani, I., & Peitl, V. (2011). Symptoms of agitated depression and/or akathisia.. PubMed.
384. Pelc, I. (1997). [Alcoholism: relapse prevention].. PubMed.
385. Peretti, C.-S., Ferreri, F., & Crucis, B. (2009). Troubles cognitifs dans la dépression. La Lettre du psychiatre.
386. Perkinson, R. R., & Jongsma, A. E. (1997). The Chemical Dependence Treatment Planner.
387. Peña, D. A., Pérez, M. L., & Pinzón, L. F. C. (2014). Línea de investigación psicología clínica y de la salud..
388. Peña, M. A. M. (2013). Síndrome de sobreentrenamiento. IATREIA.
389. Piccolo, A. C., Campos, L. M. G., & Audi, M. (2025). RELAÇÃO ENTRE A QUALIDADE DO SONO, PERCEPÇÃO CORPORAL E OS SINTOMAS MOTORES E SENSITIVOS EM PESSOAS COM ESCLEROSE MÚLTIPLA REMITENTE-RECORRENTE. Aracê.. https://doi.org/10.56238/arev7n8-002
390. Piendl, T. A. (2015). Auswirkungen von depressiven Störungen auf die kognitive Leistungsfähigkeit und die Fahrkompetenz.
391. Pikirenia, U., Fedotov, I., Tuchina, O., & Kapytau, A. U. (2017). Cognitive impairment due to alcohol abuse: current status of research. Vestnik of Saint Petersburg University Medicine. https://doi.org/10.21638/11701/spbu11.2017.306
392. Pitchot, W., & Dor, B. (2019). [Psychiatric complications associated with alcoholism].. PubMed.
393. Pitkanen, M. L., Stevens, T. H., & Kopelman, M. D. (2010). Neuropsychiatric disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199204854.003.2604
394. Pohl, M. I. (1988). Neurocognitive Impairment in Alcoholics:. Advances in Alcohol & Substance Abuse. https://doi.org/10.1300/j251v07n02_10
395. Poirier, M. F., & Ginestet, D. (1995). [Drugs diverted from reaching drug addicts].. PubMed.
396. Popa, T., & Delcea, C. (2019). Voyeurism and Scopophilia. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.11.121
397. Portnoi, V. A. (1979). Thyrotoxicosis as a mimic of dementia and/or stroke-like syndrome. Postgraduate Medicine. https://doi.org/10.1080/00325481.1979.11715283
398. Potvin, O., Hudon, C., Grenier, S., & Préville, M. (2010). Non-essential symptoms of depression and cognitive impairment no dementia (CIND) in community-dwelling elders without dysphoria or anhedonia. International Psychogeriatrics. https://doi.org/10.1017/s1041610210001419
399. Power, J., Watson, S., Chen, W., Lewis, A. J., IJzendoorn, M. H. V., & Galbally, M. (2023). The trajectory of maternal perinatal depressive symptoms predicts executive function in early childhood. Psychological Medicine. https://doi.org/10.1017/s0033291723002118
400. Powers, R. E. (2006). A PATIENT'S GUIDE FOR PERSONS WITH DEMENTIA OR ALZHEIMER'S DISEASE 1. WHAT IF I THINK I HAVE ALZHEIMER'S DISEASE OR MY DOCTOR TELLS ME I HAVE DEMENTIA? 1.1. Understanding How My Memory Works.
401. Pozuelo, L., Franco, K., & Palmer, R. M. (1998). Agitated dementia: Drug vs nondrug treatment. Cleveland Clinic Journal of Medicine. https://doi.org/10.3949/ccjm.65.4.191
402. Prajapati, B., Agarwal, A., Garg, D., Garg, A., Pandit, A., Radhakrishnan, D. M., & Srivastava, A. (2024). Delayed post-hypoxic parkinsonism with leukoencephalopathy associated with carbon monoxide poisoning. Annals of Movement Disorders. https://doi.org/10.4103/aomd.aomd_37_24
403. Preuss, U. W., Wong, W., & Farren, C. K. (2014). Chapter 9: Bipolar Affective Disorders and Alcohol Dependence: Comorbidity, Consequences Consequences, and Treatment.
404. Quadri, M. (2013). Finding Genes for Parkinsonism.
405. Queiroz, A. P. D. S., Pedro, M. O. P., Campos, M. W., Torales, J., Ventriglio, A., & Castaldelli-Maia, J. M. (2025). Cognitive Effects of Cannabis Use: A Comprehensive Review Across Domains. Neurology International. https://doi.org/10.3390/neurolint17070107
406. Rabinerson, D., Ben‐Shitrit, G., & Glezerman, M. (2011). [Lethal sex].. PubMed.
407. Radanovic, M., Stella, F., & Forlenza, O. V. (2015). Comprometimento cognitivo leve. Revista de Medicina. https://doi.org/10.11606/issn.1679-9836.v94i3p162-168
408. Raju, V. R. (2023). Awareness of medical issues in health sciences and in scientific technological education. IP Journal of Nutrition Metabolism and Health Science. https://doi.org/10.18231/j.ijnmhs.2023.018
409. Ramsay, D. A. (2014). Ethanol, Trauma, and the Brain. Academic Forensic Pathology. https://doi.org/10.23907/2014.030
410. Realpe, B. L. C. (2013). Estudio comparativo de la acción psicofarmacológica y analgésica de extractos de plantas de uso terapéutico tradicional con antidepresivos inhibidores selectivos de la recaptación de monoaminas.
411. Redaktion, D. (2003). Stabisme et consommation de drogues - Otite moyenne aiguë et vaccination contre le pneumocoque - D'habitude, l'autisme commence à l'âge de 2-3 ans - thérapie manipulatoire - variole des singes - Existe-t-il une association. Forum Médical Suisse ‒ Swiss Medical Forum. https://doi.org/10.4414/fms.2003.05022
412. Resch, M. (2010). The psychological factors affecting athletic performance. Orvosi Hetilap. https://doi.org/10.1556/oh.2010.28890
413. Ridzoň, P. (2022). Benign fasciculation syndrome. Neurologie pro praxi. https://doi.org/10.36290/neu.2021.075
414. Rietveld, S. (1998). Symptom Perception in Asthma: A Multidisciplinary Review. Journal of Asthma. https://doi.org/10.3109/02770909809068201
415. Rigaud, J., Lheureux, P., & Sauder, P. (2006). Prise en charge symptomatique : neurologique, respiratoire, hémodynamique et hépatique des intoxications graves par médicaments et substances illicites. Réanimation. https://doi.org/10.1016/j.reaurg.2006.08.002
416. Riofrío, I. P. B., Jefe, M., De, D., Mental, S., Miller, H., Mt, S., Psiquiatría, D., Dra, H., Velastegui, G. N. J., medico, Psc, R., Alexandra, C., & Torres, L. (2019). Síndrome Neuroléptico Maligno: A propósito de un caso clínico. https://doi.org/10.36015/cambios.v16.n1.2017.279
417. Ritz, L., Pitel, A., Vabret, F., Eustache, F., & Beaunieux, H. (2012). Alcoolodépendance : atteintes neuropsychologiques et diagnostics différentiels. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2012.0227
418. Ritz, L., Pitel, A., Vabret, F., Eustache, F., & Beaunieux, H. (2012). Alcoolodépendance : atteintes neuropsychologiques et diagnostics différentiels. Revue de neuropsychologie. https://doi.org/10.3917/rne.043.0196
419. Rizvi, N., Whitty, M., & Daly, R. J. (2010). Absinthe and suicidality. Irish Journal of Psychological Medicine. https://doi.org/10.1017/s0790966700000914
420. Robert, P. (2006). Is ecstasy a dangerous drug?. Kontakt. https://doi.org/10.32725/kont.2006.025
421. Roberts, A. J., & Koob, G. F. (1997). The neurobiology of addiction: an overview.. PubMed.
422. Robison, D., & Hunt, S. D. (2005). Sudden In-Custody Death Syndrome.
423. Rodrigo, M. L., Monge, M. P., Fominaya, M. P., Oliver, A. O., Guerra, M. T., Montero, C. G., & Font, V. R. (2022). Two of us live in this body. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2022.2256
424. Rodriguez, C. P., Dodds, T., & Suzuki, J. (2017). Addiction. Pain Medicine. https://doi.org/10.1007/978-3-319-43133-8_33
425. Rodríguez, E. O., Martı́nez-Raga, J., Gómez, M. C., Gálvez, B. P., Ferragut, A. S., & Martínez, G. C. (2003). Complicaciones físicas del consumo de drogas recreativas. Adicciones. https://doi.org/10.20882/adicciones.462
426. Rodríguez, F. D., Sánchez, M. L., & Coveñas, R. (2023). Neurotensin and Alcohol Use Disorders: Towards a Pharmacological Treatment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24108656
427. Roessner, V., & Rothenberger, A. (2014). Tic Disorders. https://doi.org/10.1007/978-3-7091-1501-5_27
428. Rollin‐Sillaire, A., Delbeuck, X., Pollet, M., Mackowiak, M., Lenfant, P., Noël, M., Façon, T., Leleu, X., Pasquier, F., & Rhun, É. L. (2013). Memory loss during lenalidomide treatment: a report on two cases. BMC Pharmacology and Toxicology. https://doi.org/10.1186/2050-6511-14-41
429. Romero, M. Á., López, A. M., & González, B. G. (2011). Adicciones psicológicas: perspectiva psicosomática..
430. Ronad, S. V., Patail, C. S., Gondbal, S. H., TC, K., Ronad, M., Pankaja, T., Badesgol, R., & Singhal, P. K. J. (2019). Professionals in metro cities suffer from anxiety disorder. Nursing & Care Open Access Journal. https://doi.org/10.15406/ncoaj.2019.06.00198
431. Roques, B. (2000). La dangerosité des drogues : mécanismes neurobiologiques des addictions et approches thérapeutiques.. médecine/sciences. https://doi.org/10.4267/10608/1588
432. Rosenberg, D. L., & Latorre, J. G. (2015). Hearing One’s Voice in Your Speech. The Neurologist. https://doi.org/10.1097/nrl.0000000000000069
433. Rousseau, P. (1988). Impotence in elderly men. Postgraduate Medicine. https://doi.org/10.1080/00325481.1988.11700270
434. Roy, A. (1996). Aetiology of Secondary Depression in Male Alcoholics. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.169.6.753
435. Sabo-Graham, T., & Seay, A. R. (1998). Consultation with the Specialist: Management of Status Epilepticus in Children. Pediatrics in Review. https://doi.org/10.1542/pir.19.9.306
436. Sadiq, H., & Abakah, S. (2015). Depression and Its Relation with Blood Group According Differences (Sex).
437. Saeed, S. A., & Tj, B. (1998). Panic disorder: effective treatment options.. PubMed.
438. Saha, A. (2015). Sexual Disorders Seen in Alcohol Dependent Patients. American Journal of Psychiatry and Neuroscience. https://doi.org/10.11648/j.ajpn.20150302.13
439. Sahakian, B. J., & Morein‐Zamir, S. (2011). Depression and resilience: insights from cognitive, neuroimaging, and psychopharmacological studies. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780199600434.003.0023
440. Sahoo, M. K., & Biswas, H. (2021). Disulfiram-induced seizure in a patient with alcohol dependence syndrome. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_149_20
441. Saitz, R. (1998). Introduction to alcohol withdrawal.. PubMed.
442. Salahuddin, M., Singh, P. K., Rathour, S., Jain, S., & Bijarnia, M. (2021). POOR CONFIDENCE DUE TO STAMMERING AND ITS HOMOEOPATHIC MANAGEMENT. International Journal of AYUSH.
443. Sanchis‐Segura, C., & Spanagel, R. (2006). REVIEW: Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addiction Biology. https://doi.org/10.1111/j.1369-1600.2006.00012.x
444. Sandi, C. (2013). Stress and cognition. Wiley Interdisciplinary Reviews Cognitive Science. https://doi.org/10.1002/wcs.1222
445. Sandoval-Munoz, C. P., & Haidar, Z. S. (2021). Neuro-Muscular Dentistry: the “diamond” concept of electro-stimulation potential for stomato-gnathic and oro-dental conditions. Head & Face Medicine. https://doi.org/10.1186/s13005-021-00257-3
446. Sanz, G. L., Ruíz, E. C., & Vázquez, L. S. (2015). Síndrome confusional ag udo en pacientes de edad avanzada con fractura de fémur. Ágora de enfermería.
447. Sarappa, C., Veneri, R. D., & Muscettola, G. (2007). Un caso di encefalopatia da sali di litio: il ruolo diagnostico dell'EEG. Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology.
448. Sarkar, S., Bhatia, G., & Dhawan, A. (2023). Clinical Practice Guidelines for Assessment and Management of Patients with Substance Intoxication Presenting to the Emergency Department. Indian Journal of Psychiatry. https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_490_22
449. Sarris, J., O’Neil, A., Coulson, C., Schweitzer, I., & Berk, M. (2014). Lifestyle medicine for depression. BMC Psychiatry. https://doi.org/10.1186/1471-244x-14-107
450. Sasnauskaitė, A., Lebiodaitė, R. B., & Musneckis, A. (2024). BIPOLINIS AFEKTINIS SUTRIKIMAS, MANIJA SU PSICHOZĖS SIMPTOMAIS IR ILGALAIKIS PSICHOAKTYVIŲJŲ MEDŽIAGŲ VARTOJIMAS. KLINIKINIS ATVEJIS. Health Sciences. https://doi.org/10.35988/sm-hs.2024.331
451. Saunders, J. B. (2011). The Biology of Alcohol and Alcohol Misuse. https://doi.org/10.1002/9781118785089.ch4
452. Sayarifard, A., & Ghadirian, L. (2013). Mental health literacy in iran: an urgent need for a remedy.. PubMed.
453. Schildkrout, B. (2014). Delirium. https://doi.org/10.1002/9781394260447.ch2
454. Schildkrout, B. (2014). Disease #18: Hepatic Encephalopathy. https://doi.org/10.1002/9781394260447.ch46
455. Schildkrout, B. (2014). Hallucinations. https://doi.org/10.1002/9781394260447.ch8
456. Schmauß, M., & Pajonk, F. (2015). Agitation und Aggression in der Psychiatrie. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-0041-111184
457. Schuckit, M. A. (1996). Alcohol, Anxiety, and Depressive Disorders.. PubMed.
458. Schulman, E. A. (2011). Abuse and Maltreatment: Their Effect on Headache. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.2011.02020.x
459. Schutte, M., Mathias, B., & Hopf, G. (1988). [Adverse effects of antihistaminics].. PubMed.
460. Scotton, W. J., Hill, L. J., Williams, A., & Barnes, N. M. (2019). Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions. International Journal of Tryptophan Research. https://doi.org/10.1177/1178646919873925
461. Sejdić, E., Malandraki, G. A., & Coyle, J. L. (2018). Computational Deglutition: Using Signal- and Image-Processing Methods to Understand Swallowing and Associated Disorders [Life Sciences]. IEEE Signal Processing Magazine. https://doi.org/10.1109/msp.2018.2875863
462. Sharma, P., Dubey, A., Das, D., Ivaturi, N. V., Kumar, D., & Rajput, M. (2023). Marchiafava–Bignami Disease: A Rare Finding in Alcohol Dependence Syndrome. Journal of Marine Medical Society. https://doi.org/10.4103/jmms.jmms_5_23
463. Sharma, S., Nepal, B., Moon, C. S., Chabenne, A., Khogali, A., Ojo, C., Hong, E., Gaudet, R., Sayed-Ahmad, A., Jacob, A., Murtuza, M., & Firlit, M. L. (2014). Psychology of Craving. Open Journal of Medical Psychology. https://doi.org/10.4236/ojmp.2014.32015
464. Sharpe, M. (2010). Chronic fatigue syndrome (postviral fatigue syndrome, neurasthenia, and myalgic encephalomyelitis). Oxford University Press eBooks. https://doi.org/10.1093/med/9780199204854.003.260504
465. Sheets, E. S., & Brosse, A. L. (2010). Major Depressive Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0522
466. Shields, L. B. E., Rolf, C. M., & Hunsaker, J. C. (2015). Sudden Death Due To Acute Cocaine Toxicity—Excited Delirium in a Body Packer. Journal of Forensic Sciences. https://doi.org/10.1111/1556-4029.12860
467. Silber, T. J. (1987). A Variant of Hoigne's Syndrome Following Intramuscular Cefoxitin Sodium?. Archives of Pediatrics and Adolescent Medicine. https://doi.org/10.1001/archpedi.1987.04460050017008
468. Silva, L. I. F. D., Souza, L. M., Gonzales, M. F., & Jurado, S. R. (2015). SLEEP DISORDERS IN CHILDHOOD. Simpósio Internacional de Neurociências da Grande Dourados.
469. Silva, M. A. M. D. V., Paixão, M. R. S. D., Silva, M. L. D., Garcia, M. C. M., Boschilia, M. O., Oliveira, K. B. D., Marques, I. A., Baruf, B. D. S., Souza, L. C. D., Teodoro, A. A. C., Vargas, G. L., & Silva, A. D. P. (2022). COMPLICATIONS NEUROLOGICAL ACUTE FUR CONSUMPTION OF ALCOHOL: A LITERATURE REVIEW. International Journal of Human Sciences Research. https://doi.org/10.22533/at.ed.5582172230064
470. Silva, T. D. O., Leite, J. R., Bezerra, W. D. S. P., Lima, M. B. L. D., & Fiorin, P. M. (2017). A DEPRESSÃO NA TERCEIRA IDADE:RELATO DE EXPERIÊNCIA DE UMA ATIVIDADE EDUCATIVA.
471. Silverstein, E., Basiru, T., Aulakh, M., Verzura, M. L., & Suarez, R. (2025). Management of Acute Onset Catatonia Postpartum in a Patient With a History of Major Depressive Disorder With Psychotic Features: A Case Report. Cureus. https://doi.org/10.7759/cureus.84392
472. Simonson, W., & Wj, F. (1996). Drug therapy implications on activity: a focus on the elderly patient.. PubMed.
473. Singh, G., & Kaur, P. (2017). ANTIPSCYHOTIC INDIAN HERBAL FORMULATIONS: AN OVERVIEW. Indian Research Journal of Pharmacy and Science. https://doi.org/10.21276/irjps.2017.4.1.6
474. Singh, S. (2015). Mental health in infancy. International Journal of Clinical & Medical Imaging. https://doi.org/10.4172/2376-0249.1000393
475. Skike, C. E. V., Goodlett, C. R., & Matthews, D. B. (2019). Acute Alcohol and Cognition: Remembering What It Causes Us to Forget. Author eBooks.
476. Slobodin, G., & Odeh, M. (2015). Progressive Brain Atrophy due to Chronic Alcohol Abuse.. PubMed.
477. Smith, B. H., Molina, B. S. G., & Pelham, W. E. (2002). The Clinically Meaningful Link Between Alcohol Use and Attention Deficit Hyperactivity Disorder.. Alcohol Research & Health.
478. Smith, G. T., Zapolski, T. C. B., Combs, J. L., & Friend, R. E. (2010). Impulsivity. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0436
479. Smith, H. S., & Jackson, K. C. (2008). Optimizing pharmacologic outcomes: Drug selection. https://doi.org/10.1093/oso/9780195339499.003.0005
480. Smith, P. E. M. (1998). Key Topics in Neurology.
481. Smith, P. J., & Blumenthal, J. A. (2015). Exercise and Physical Activity in the Prevention and Treatment of Depression. Routledge eBooks. https://doi.org/10.4324/9780203132678.ch8
482. Soares, E. B., Pires, J. B., Menezes, M. D. A., Santana, S. K. S. D., & Fraga, J. (2010). Fonoaudiologia X ronco/apneia do sono. Revista CEFAC. https://doi.org/10.1590/s1516-18462010000200019
483. Solimini, R., Rotolo, M. C., Pichini, S., & Pacifici, R. (2017). Neurological Disorders in Medical Use of Cannabis: An Update. CNS & Neurological Disorders - Drug Targets. https://doi.org/10.2174/1871527316666170413105421
484. Soliz, J., Lia, O. V. V., Moya, J. M. F., & López, E. T. (2009). Consumo de Alcohol durante el Embarazo: Múltiples Efectos Negativos en el Feto.
485. Soysal, P., & Işık, A. T. (2014). Hypoactive Delirium Caused by Pulmonary Embolus in an Elderly Adult. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.12720
486. Spada, M. M., Caselli, G., & Wells, A. (2012). A Triphasic Metacognitive Formulation of Problem Drinking. Clinical Psychology & Psychotherapy. https://doi.org/10.1002/cpp.1791
487. Spanagel, R. (2003). Behavioral and Molecular Aspects of Alcohol Craving and Relapse. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-343-9_15
488. Spiegel, E. P., & Vanderploeg, R. D. (2010). Postconcussion Syndrome. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0696
489. Sriramoju, M., Keerthi, V. P., Alumdri, D. B., & Akula, S. (2014). Evaluation of antidepressant activity of ethanolic and aqueous extract of Solanum tuberosum peel. Journal of Comprehensive Pharmacy. https://doi.org/10.37483/jcp.2014.1503
490. Stankewicz, H., Richards, J. R., & Salen, P. (2017). Alcohol Related Psychosis. StatPearls.
491. Steffens, D. C., Blazer, D. G., & Beyer, J. L. (2013). Mood Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370016.mt05
492. Stohler, R., Rommelspacher, H., Ladewig, D., & Dammann, G. (1993). [Beta-carbolines (harman/norharman) are increased in heroin dependent patients].. PubMed.
493. Stone, J., Pal, S., Blackburn, D., Reuber, M., Thekkumpurath, P., & Carson, A. (2015). Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-150430
494. Stratakis, C. A., Gold, P. W., & Chrousos, G. P. (1995). Neuroendocrinology of Stress: Implications for Growth and Development. Hormone Research. https://doi.org/10.1159/000184269
495. Stubbe, D. (2007). Child and adolescent psychiatry : a practical guide. Lippincott Williams & Wilkins eBooks.
496. Sugimoto, A., Futamura, A., & Kawamura, M. (2013). [Epilepsy and cognitive dysfunction].. PubMed.
497. Sumiyoshi, T., Matsuoka, T., & Kurachi, M. (2012). Role for Pituitary Neuropeptides in Social Behavior Disturbances of Schizophrenia. InTech eBooks. https://doi.org/10.5772/52326
498. Summers, C. B. (2007). Cognitive-Behavior Group Therapy in Residential Treatment. https://doi.org/10.4324/9780203941157-16
499. Szaffarczyk, S., Lapierre, P., Danel, T., Cottencin, O., & Pins, D. (2015). Étude du sentiment de familiarité dans l’alcoolo-dépendance : une hyperfamiliarité aux visages. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2015.09.199
500. Szyguła‐Jurkiewicz, B., Szymik, M., Mrozowska, B., Schmidt, B., & Michalak, A. (2011). Psychologiczne uwarunkowania i konsekwencje ostrego zawału serca. Leki psychotropowe u chorych po ostrym zawale serca. Choroby Serca i Naczyń.
501. TAKANASHI, M. (2010). パーキンソン病の非運動症状. Juntendō Igaku/Juntendo igaku. https://doi.org/10.14789/pjmj.56.444
502. Tang‐Wai, D. F., Josephs, K. A., & Petersen, R. C. (2005). Alzheimer's disease: overview. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544873.029
503. Tani, M., & Iwanami, A. (2013). [Disorder of train of thought in the elderly].. PubMed.
504. Tatsuzawa, Y., Ono, Y., Takahashi, T., Yoshino, A., & Nomura, S. (2011). Case of isolated adrenocorticotropic hormone deficiency mimicking major depressive disorder. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/j.1440-1819.2011.02207.x
505. Thakkar, K., Shah, K., Rana, D., Malhotra, S., & Patel, P. (2017). Amlodipine drug therapeutic failure: a rare case report. International Journal of Basic & Clinical Pharmacology. https://doi.org/10.18203/2319-2003.ijbcp20175700
506. Thomas, N., & Pantelis, C. (2015). Psychotic Disorders. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp535
507. Thomsen, L. L., & Olesen, J. (2013). Autonomic aspects of migraine: pathophysiology and treatment. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198566342.003.0070
508. Thomsen, T., & Miyasaki, J. M. (2012). Psychogenic Movement Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-120-2_7
509. Tiglao, S. M., Meisenheimer, E. S., & Oh, R. (2021). Alcohol Withdrawal Syndrome: Outpatient Management.. American family physician.
510. Tobutt, C. (2015). Alcohol: brief interventions for hazardous drinking and dependency. British Journal of Mental Health Nursing. https://doi.org/10.12968/bjmh.2015.4.2.87
511. Torpy, J. M. (2010). Delirium. JAMA. https://doi.org/10.1001/jama.304.7.814
512. Torrez, R. D. A., Mercado, A. N. F., Vargas, K. P. C., & Luza, P. L. (2012). Necrosis del cuerpo calloso: Síndrome de Marchiafava - Bignami. DOAJ (DOAJ: Directory of Open Access Journals).
513. Touze, M.-D., Potel, G., & Baron, D. (1993). [Acute ethyl alcohol intoxication].. PubMed.
514. Toyoda, C. Y., & Silva, L. M. F. D. (2015). Orientação domiciliar a familiares e cuidadores de pacientes com acidente vascular encefálico: papel do terapeuta ocupacional.
515. Tp, P., & Ms, D. (1987). [The current understanding of so-called exceptional states in the forensic psychiatry clinic].. PubMed.
516. Trachtenberg, M. C., & Blum, K. (1987). Alcohol and Opioid Peptides: Neuropharmacological Rationale for Physical Craving of Alcohol. The American Journal of Drug and Alcohol Abuse. https://doi.org/10.3109/00952998709001520
517. Trevisan, L., Boutros, N. N., Petrakis, I. L., & Krystal, J. H. (1998). Complications of alcohol withdrawal: pathophysiological insights.. PubMed.
518. Trill, M. D. (2012). Psychological aspects of depression in cancer patients: an update. Annals of Oncology. https://doi.org/10.1093/annonc/mds350
519. Trojak, B., Leclerq, S., Meille, V., Khoumri, C., Chauvet‐Gélinier, J., Giroud, M., Bonin, B., & Gisselmann, A. (2011). Stroke with neuropsychiatric sequelae after cannabis use in a man: a case report. Journal of Medical Case Reports. https://doi.org/10.1186/1752-1947-5-264
520. Trojanowska, M. (2017). Społeczny i medyczny wymiar seksualności osób z niepełnosprawnością na przykładzie osób chorych na stwardnienie rozsiane. Acta Universitatis Lodziensis Folia Sociologica. https://doi.org/10.18778/0208-600x.60.08
521. Umut, G., Küçükparlak, İ., Özgen, G., & Türkcan, A. (2011). Esrar Kullanımı Sırasında Başlayan ve N, N- Dimetiltriptamin (Dmt) Kullanımı ile Psikotik Özellikler Eklenen Duygudurum Bozukluğu: Bir Olgu Sunumu / A Mood Disorder Episode with an Onset Under Chronic Cannabis Consumption, and Accompanied With Psychotic Features Immediately After N,N-Dimethyltryptamine (Dmt) Use: A Case Report. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. https://doi.org/10.5350/dajpn2011240312
522. Vargas, J. K. R. F. (1999). Artículos de Revisión.
523. Vataja, R., & Leppävuori, A. (2012). [Assessment and treatment of conversion disorder: the most fascinating borderline of psychiatry and neurology].. PubMed.
524. Velasco-Rey, M. C., Sánchez-Muñoz, M., Lopez, M., Trujillo-Borrego, A., & Sánchez-Bonome, L. (2012). Psychotic depression induced by Obstructive Sleep Apnoea Syndrome (OSAS): a case reported.. PubMed.
525. Velleman, S. L., & Mervis, C. Β. (2011). Children With 7q11.23 Duplication Syndrome: Speech, Language, Cognitive, and Behavioral Characteristics and Their Implications for Intervention. Perspectives on Language Learning and Education. https://doi.org/10.1044/lle18.3.108
526. Venkataraman, R., Patodia, S., & Thiriveedhi, R. N. (2023). Thrombocytopenia in the Critically Ill: An Animal with Several Heads. Indian Journal of Critical Care Case Report. https://doi.org/10.5005/jp-journals-11006-0089
527. Verster, J. C., Klerk, S. D., Bervoets, A. C., & Kruisselbrink, L. D. (2013). Can Hangover Immunity be Really Claimed.
528. Vezzosi, D., Bennet, A., Maïza, J.-C., Buffet, A., Grunenwald, S., Fauvel, J., Courbon, F., Otal, P., Carrère, N., & Caro, P. (2011). Diagnosis and Treatment of Insulinomas in the Adults. InTech eBooks. https://doi.org/10.5772/17452
529. Vilibić, M., Jukić, V., Vidović, A., & Brečić, P. (2013). Cobalamin deficiency manifested with seizures, mood oscillations, psychotic features and reversible dementia in the absence of typical neurologic and hematologic signs and symptoms: a case report.. PubMed.
530. Violon, A., & Lebrun, G. (1979). [Memory alterations in non-korsakoff's chronic alcoholics (author's transl)].. PubMed.
531. Vivanco, E. F., Gómez, C. P., & Martínez, R. G. (2006). Patología orgànica por drogas de síntesis. Adicciones.
532. Wakefield, J. C. (2015). DSM-5 substance use disorder: how conceptual missteps weakened the foundations of the addictive disorders field. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.12446
533. Walther, M., & Woods, D. W. (2010). Trichotillomania. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy1011
534. Walton, J. C., & Miller, J. M. (1998). Evaluating physical and behavioral changes in older adults.. PubMed.
535. Ward, R., & Manchip, S. (2012). ‘Inappropriate’ sexual behaviours in dementia. Reviews in Clinical Gerontology. https://doi.org/10.1017/s0959259812000196
536. Weber, P., Vepřeková, B., & Kadaňka, Z. (2009). Psychiatrická problematika v intenzivní medicíně vyššího věku.
537. Weis, S., Sonnberger, M., Dunzinger, A., Voglmayr, E., Aichholzer, M., Kleiser, R., & Strasser, P. (2019). Intoxication: Alcohol. https://doi.org/10.1007/978-3-7091-1544-2_49
538. Weiss, F., & Porrino, L. J. (2002). Behavioral Neurobiology of Alcohol Addiction: Recent Advances and Challenges. Journal of Neuroscience. https://doi.org/10.1523/jneurosci.22-09-03332.2002
539. Wet, E. D. (2006). Indicators of teenage drug abuse : social skills. SA pharmacist's assistant/South African pharmacist's assistant.
540. Whelan, G. (1995). Alcohol‐related health problems in the elderly. The Medical Journal of Australia. https://doi.org/10.5694/j.1326-5377.1995.tb139915.x
541. Wijdicks, E. F. M. (2025). Neurology of Overdose. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197544976.003.0052
542. Wijdicks, E. F. M. (2025). “Blacked Out and Slumped Down”. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197544976.003.0007
543. Williams, R. H., & Erickson, T. B. (2000). Evaluating Hallucinogenic or Psychedelic Drug Intoxication in an Emergency Setting. Laboratory Medicine. https://doi.org/10.1309/v3j8-3kw2-bpt1-fu15
544. Winbigler, B. L., & Chyka, P. A. (2022). Chapter 43: Substance Misuse and Toxicology. The American Pharmacists Association eBooks. https://doi.org/10.21019/9781582123615.ch43
545. Winters, K. C., & Ingwalson, A. (2022). Adolescent Brain Development. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190678487.003.0003
546. Winters, K. C., & Ingwalson, A. (2022). Internalizing and Related Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190678487.003.0006
547. Winters, K. C., & Ingwalson, A. (2022). Substance Use Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190678487.003.0005
548. Wittmann, M., Back, C. A., & Haen, E. (2010). Verwirrtheitszustände als wichtige Arzneimittelwirkung. Therapeutische Umschau. https://doi.org/10.1024/0040-5930/a000116
549. Wolraich, M. L. (1996). Disorders of development & learning : a practical guide to assessment and management. Mosby eBooks.
550. Wr, Y., Meller, W. H., & Ep, T. (1987). Behavioral complications of alcoholism.. PubMed.
551. Wyatt, J. P., Illingworth, R. N., Graham, C. A., Hogg, K., Clancy, M., & Robertson, C. E. (2012). Environmental emergencies. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199589562.003.0006
552. Wölfling, K., Müller, K., Dreier, M., & Beutel, M. (2019). Verbesserung kognitiver Performance und psychischem Funktionsniveau nach verhaltenstherapeutischer Behandlung von Patienten mit Internetsucht. Suchttherapie. https://doi.org/10.1055/s-0039-1696221
553. Xiao, S., Wang, Y., Duan, S., & Li, B. (2021). Effects of Aromatherapy on Agitation and Aggression in Cognitive Impairment: A Protocol for Meta-Analysis. https://doi.org/10.37766/inplasy2021.6.0095
554. Yani, F. (2015). Kelainan Mental Manik Tipe Skizoafektif. Jurnal Medula.
555. Yarlagadda, A. R., Brown, A. B., & Clayton, A. H. (2007). Onset of Obstructive Sleep Apnea After Initiation of Psychotropic Agents. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0611h
556. Yersin, B. (1999). [Ambulatory management of alcohol withdrawal syndrome].. PubMed.
557. Young, W. B., Packard, R. C., & Katsarava, Z. (2007). Headaches Associated with Head Trauma. https://doi.org/10.1093/oso/9780195326567.003.0016
558. Youssef, P. E. (2022). Childhood Neurologic Conditions: Movement Disorders.. PubMed.
559. Yrondi, A., Rey, R., Scoriels, L., Godin, O., & Leboyer, M. (2025). L’anhédonie. médecine/sciences. https://doi.org/10.1051/medsci/2025062
560. Zanini, R. S., Almeida, G. M. F. D., Helegda, L. C., & Fernandes, K. C. (2014). DEMENCIA DE WERNICKE KORSAKOFF, USO E ABUSO DE SUBSTANCIAS: REPERCUSSÕES NEUROPSICOLÓGICAS E PSICOMOTORAS.. Fiep Bulletin - online.
561. Zheng, Z., Zou, K., Huang, J., Yang, J., Zhou, J., Xiong, R., & Li, Y. (2023). Schizophrenia. https://doi.org/10.1007/978-981-99-4538-2_20
562. Zutshi, A., Math, S. B., & Reddy, Y. C. J. (2007). Escitalopram in Obsessive-Compulsive Disorder. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0611c